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Summary
The STROBE (Strengthening the Reporting of Observational Studies in Epidemiol-
ogy) statement was first published in 2007 and again in 2014. The purpose of the origi-
nal STROBE was to provide guidance for authors, reviewers and editors to improve
the comprehensiveness of reporting; however, STROBE has a unique focus on obser-
vational studies. Although much of the guidance provided by the original STROBE
document is directly applicable, it was deemed useful to map those statements to vet-
erinary concepts, provide veterinary examples and highlight unique aspects of report-
ing in veterinary observational studies. Here, we present the examples and
explanations for the checklist items included in the STROBE-Vet Statement. Thus, this
is a companion document to the STROBE-Vet Statement Methods and process docu-
ment, which describes the checklist and how it was developed.
Introduction
In veterinary research, observational studies are commonly
used to describe the natural history of disease, assess aetiol-
ogy, and identify and investigate the effect of risk factors.
To maximize the value of observational studies, it is critical
that they are reported in a manner that facilitates internal
and external validity assessment. Reporting guidelines allow
researchers to appraise the published findings and poten-
tially apply them to future research or decision-making.
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Zoonoses and Public Health
Initially used for intervention (clinical trial) assessments,
the CONSORT (Moher et al., 2001; Schulz et al., 2010)
and REFLECT statements (O’Connor et al., 2010; Sargeant
et al., 2010) were developed to create an experimental and
reporting framework for randomized controlled trials and
to help authors, reviewers and editors address concerns
about incomplete reporting. The STROBE (Strengthening
the Reporting of Observational Studies in Epidemiology)
statement, first published in 2007 and again in 2014 (von
Elm et al., 2007; Vandenbroucke et al., 2007, 2014), pro-
vided a similar framework for observational studies. In this
document, we provide the rationale behind the revision of
STROBE for use in veterinary research and examples of data
reporting under the revised guidelines. While much of the
STROBE material is directly relevant to veterinary studies,
animal health investigations have sufficient unique features
to warrant publishing a set of veterinary-investigator-speci-
fic guidelines (reference Process document). For example,
multiple levels of organization are common in animal popu-
lations, and observational studies should account for this
when reporting results. Given the importance of population
structures when interpreting results, this issue features
prominently in the STROBE-Vet extension.
Omission or unclear reporting of important details is a
common problem in all types of research reports. Some
omissions can seriously limit the utility of the research by
either hiding limitations or creating unwarranted doubt
about the study conclusions These omissions, in turn,
increase research wastage (Fanelli, 2013; Al-Shahi Salman
et al., 2014; Chan et al., 2014; Ioannidis et al., 2014;
Macleod et al., 2014; Moher et al., 2016). Study results are
usually used by people other than the manuscript authors to
make decisions. Hence, these users need as much informa-
tion as possible to judge the validity of the results. Reporting
guidelines are designed to reduce critical omissions by pro-
viding a checklist of important items to include in the
report. Checklists improve author, editor and reviewer com-
pliance with respect to what information should be included
in a comprehensive report, making them valuable research-
reporting tools (Haynes et al., 2015; Kim et al., 2015).
How to Use this Document
Each item is presented in the same manner: first the item
number (1 to 22) with subdivisions and a description of
the item, followed by examples that illustrate the report-
ing approach for the item and a discussion of the ratio-
nale for their inclusion. Ideally, the examples chosen
would illustrate all of the key concepts, and only those
concepts. However, it was not always possible to identify
such specific real-world examples from the veterinary lit-
erature. The working group decided not to use human
healthcare or hypothetical examples. As a consequence,
the examples sometimes include additional examples or sev-
eral examples were needed to illustrate the key concepts.
When the explanation for an item was the same as that
reported in the original STROBE publication, we used the
material ad verbatim, with permission from the original
authors. Examples of poorly reported items were not
included due to space considerations and the consensus that
their inclusion would not substantially increase understanding
or adoption of the guidelines. A table with the STROBE-Vet
checklist is included at the end of this document (Table 1).
Title and Abstract
The purpose of the abstract and title is to quickly allow the
reader to identify the topic of the research, the general
design of the study, the main results and the implications of
the findings.
1 (a). Indicate that the study was an observational study
and, if applicable, use a common study design term
Example 1
Title: ‘An observational study with long-term follow-up of
canine cognitive dysfunction: Clinical characteristics, sur-
vival and risk factors’ (Fast et al., 2013).
Example 2
Title: ‘Case-control study of risk factors associated with
Brucella melitensis on goat farms in Peninsular Malaysia’
(Bamaiyi et al., 2014).
Explanation
Including the study design term in the title or abstract when
a standard study design is used, or at least identifying that a
study is observational, allows the reader to easily identify the
design and helps to ensure that articles are correctly indexed
in electronic databases (Benson and Hartz, 2000). In STROBE,
item 1a only requests that a common study design term be used.
However, in veterinary research, not all observational studies are
easily categorized into cohort, case–control, or cross-sectional
study designs. Therefore, we recommend including that the study
was observational and, if possible, the study design or important
design characteristics, for example longitudinal, in the title.
1 (b). Indicate why the study was conducted, the
approach, the results, the limitations and the relevance of
the findings
Example
Methicillin-resistant Staphylococcus pseudintermedius
(MRSP) has emerged as a highly drug-resistant small ani-
mal veterinary pathogen. Although often isolated from
outpatients in veterinary clinics, there is concern that
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Table 1. Strengthening the Reporting of Observational Studies in Epidemiology statement checklist for Veterinary medicine (the STROBE-Vet
statement)
Item
Title and Abstract 1 (a) Indicate that the study was an observational study and, if applicable, use a common study design term
(b) Indicate why the study was conducted, the design, the results, the limitations and the relevance of the
findings
Background/rationale 2 Explain the scientific background and rationale for the investigation being reported
Objectives 3 (a) State-specific objectives, including any primary or secondary pre-specified hypotheses or their absence
(b) Ensure that the level of organizationa is clear for each objective and hypothesis
Study design 4 Present key elements of study design early in the paper
Setting 5 (a) Describe the setting, locations and relevant dates, including periods of recruitment, exposure, follow-up
and data collection
(b) If applicable, include information at each level of organization
Participants b 6 Describe the eligibility criteria for the owners/managers and for the animals, at each relevant level of
organization
Describe the sources and methods of selection for the owners/managers and for the animals, at each relevant
level of organization
Describe the method of follow-up
(d) For matched studies, describe matching criteria and the number of matched individuals per subject (e.g.
number of controls per case)
Variables 7 (a) Clearly define all outcomes, exposures, predictors, potential confounders and effect modifiers. If
applicable, give diagnostic criteria
(b) Describe the level of organization at which each variable was measured
(c) For hypothesis-driven studies, the putative causal structure among variables should be described (a
diagram is strongly encouraged)
Data sources/
measurement
8c (a) For each variable of interest, give sources of data and details of methods of assessment (measurement). If
applicable, describe comparability of assessment methods among groups and over time
(b) If a questionnaire was used to collect data, describe its development, validation and administration
(c) Describe whether or not individuals involved in data collection were blinded, when applicable
(d) Describe any efforts to assess the accuracy of the data (including methods used for ‘data cleaning’ in
primary research, or methods used for validating secondary data)
Bias 9 Describe any efforts to address potential sources of bias due to confounding, selection or information bias
Study size 10 (a) Describe how the study size was arrived at for each relevant level of organization
(b) Describe how non-independence of measurements was incorporated into sample size considerations, if
applicable
(c) If a formal sample size calculation was used, describe the parameters, assumptions and methods that were
used, including a justification for the effect size selected
Quantitative variables 11 Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were
chosen, and why
Statistical methods 12 (a) Describe all statistical methods for each objective, at a level of detail sufficient for a knowledgeable reader
to replicate the methods. Include a description of the approaches to variable selection, control of
confounding and methods used to control for non-independence of observations
(b) Describe the rationale for examining subgroups and interactions and the methods used
(c) Explain how missing data were addressed
(d) If applicable, describe the analytical approach to loss to follow-up, matching, complex sampling and
multiplicity of analyses
(e) Describe any methods used to assess the robustness of the analyses (e.g. sensitivity analyses or quantitative
bias assessment)
Participants 13c (a) Report the numbers of owners/managers and animals at each stage of study and at each relevant level of
organization – for example, numbers eligible, included in the study, completing follow-up and analysed
(b) Give reasons for non-participation at each stage and at each relevant level of organization
(c) Consider use of a flow diagram and/or a diagram of the organizational structure
Descriptive data on
exposures and potential
confounders
14c (a) Give characteristics of study participants (e.g. demographic, clinical, social) and information on exposures
and potential confounders by group and level of organization, if applicable
(b) Indicate number of participants with missing data for each variable of interest and at all relevant levels of
organization
(c) Summarize follow-up time (e.g. average and total amount), if appropriate to the study design
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MRSP follows a veterinary-hospital associated epidemiol-
ogy. This study’s objective was to identify risk factors for
MRSP infections in dogs and cats in Germany. Clinical
isolates of MRSP cases (n = 150) and methicillin-suscep-
tible S. pseudintermedius (MSSP) controls (n = 133) and
their corresponding host signalment and medical data
covering the six months prior to staphylococcal isolation
were analysed by multivariable logistic regression. The
identity of all MRSP isolates was confirmed through
demonstration of S. intermedius-group specific nuc and
mecA. In the final model, cats (compared to dogs, OR
18.5, 95% CI 1.8–188.0, P = 0.01), animals that had been
hospitalised (OR 104.4, 95% CI 21.3–511.6, P < 0.001),
or visited veterinary clinics more frequently (>10 visits
OR 7.3, 95% CI 1.0–52.6, P = 0.049) and those that had
received topical ear medication (OR 5.1, 95% CI 1.8–
14.9, P = 0.003) or glucocorticoids (OR 22.5, 95% CI
7.0–72.6, P < 0.001) were at higher risk of MRSP infec-
tion, whereas S. pseudintermedius isolates from ears were
more likely to belong to the MSSP group (OR 0.09, 95%
CI 0.03–0.34, P < 0.001). These results indicate an
association of MRSP infection with veterinary clinic/hos-
pital settings and possibly with chronic skin disease.
There was an unexpected lack of association between
MRSP and antimicrobial therapy; this requires further
investigation . . ... (Lehner et al., 2014).
Explanation
The abstract provides key information that enables readers
to understand the key aspects of the study and decide
whether to read the article. In STROBE, item 1b recom-
mended that authors provide an informative and balanced
summary of what experiments were done, what results were
found and the implications of the findings in the abstract.
In STROBE-Vet, this item was modified to provide more
guidance on the key components that should be addressed.
The study design should be stated; however, if the study
does not correspond to a named study design such as case–
control, cross-sectional and cohort study, then the author
should describe the key elements of the study design such
as incident versus prevalent cases, and whether or not the
selection was based on outcome status (Pearce, 2012). The
abstract should succinctly describe the study objectives,
including the primary objective and primary outcome, the
exposure(s) of interest, relevant population information
such as species and the purpose (or uses) of the animals,
the study location and dates, and the number of study
units. In addition, including the organizational level at
Table 1. (Continued)
Item
Outcome data 15c (a) Report outcomes as appropriate for the study design and summarize at all relevant levels of organization
(b) For proportions and rates, report the numerator and denominator
(c) For continuous outcomes, report the number of observations and a measure of variability
Main results 16 (a) Give unadjusted estimates and, if applicable, adjusted estimates and their precision (e.g. 95% confidence
interval). Make clear which confounders and interactions were adjusted. Report all relevant parameters that
were part of the model
(b) Report category boundaries when continuous variables were categorized
(c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period
Other analyses 17 Report other analyses done, such as sensitivity/robustness analysis and analysis of subgroups
Key results 18 Summarize key results with reference to study objectives
Strengths and Limitations 19 Discuss strengths and limitations of the study, taking into account sources of potential bias or imprecision.
Discuss both direction and magnitude of any potential bias
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses,
results from similar studies and other relevant evidence
Generalizability 21 Discuss the generalizability (external validity) of the study results
Transparency 22 (a) Funding – Give the source of funding and the role of the funders for the present study and, if applicable,
for the original study on which the present article is based
(b) Conflict of interests – Describe any conflict of interests, or lack thereof, for each author
(c) Describe the authors’ roles – Provision of an authors’ declaration of transparency is recommended
(d) Ethical approval – Include information on ethical approval for use of animal and human subjects
(e) Quality standards – Describe any quality standards used in the conduct of the research
aLevel of organization recognizes that observational studies in veterinary research often deal with repeated measures (within an animal or herd) or ani-
mals that are maintained in groups (such as pens and herds); thus, the observations are not statistically independent. This non-independence has pro-
found implications for the design, analysis and results of these studies.
bThe word ‘participant’ is used in the STROBE statement. However, for the veterinary version, it is understood that ‘participant’ should be addressed
for both the animal owner/manager and for the animals themselves.
cGive such information separately for cases and controls in case–control studies and, if applicable, for exposed and unexposed groups in cohort and
cross-sectional studies.
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which the outcome was measured (e.g. herd, pen or indi-
vidual) is recommended. The presented results should
include summary outcome measures (e.g. frequency or
appropriate descriptor of central tendency such as mean or
median) and, if relevant, a clear description of the associa-
tion direction along with accompanying association mea-
sures (e.g. odds ratio) and measures of precision (e.g. 95%
confidence interval) rather than P-value alone. We discour-
age stating that an exposure is or is not significantly associ-
ated with an outcome without appropriate statistical
measures. Finally, because many veterinary observational
studies evaluate multiple potential risk factors, the abstract
should provide the number of exposure–outcome associa-
tions tested to alert the end-user to potential type I error in
the study. When multiple outcomes are observed, provide
the reader with a rationale for the outcomes presented in
the abstract, for example only statistically significant results
or the outcome of the primary hypothesis is presented.
Introduction
The aim of the introduction is to allow the reader to under-
stand the study’s context and the results’ potential to con-
tribute to current knowledge.
2. Background/rationale: explain the scientific background
and rationale for the investigation being reported
Example
The syndesmochorial placenta of cattle prevents the bovine
fetus from receiving immunoglobulins in utero; therefore,
calves are born essentially agammaglobulinemic [].1 Calves
acquire passive immunity by consuming colostrum in the
first 24 to 36 h of life []. Inadequate colostrum consumption
leads to failure of passive transfer (FPT), which has detrimental
effects on calf health and survival. As many as 40% of dairy
calves experience FPT []. However, beef and dairy calf manage-
ment is considerably different, as beef calves generally remain
with the cow post-calving and nurse ad libitum, while dairy
producers often separate calves from their dams and then
provide the colostrum. Hence, the prevalence of and risk fac-
tors for FPT in beef calves may vary substantially from those in
reports describing dairy calves. . ..’ (Waldner and Rosengren,
2009).
Explanation
The scientific background provides important context for
readers. It describes the focus and gives an overview of what
is known on a topic and what gaps in current knowledge
are addressed by the study. Background material should
note recent pertinent studies and any reviews of pertinent
studies. The background section should also include the
anticipated impact of the work.
3 (a). Objectives: state-specific objectives, including any
primary or secondary pre-specified hypotheses or their
absence
Example
The objective of this study was to investigate the effect of
track way distance and cover on the probability for lameness
in Danish dairy herds using grazing. We hypothesised that
short track distances with added cover would be associated
with the lowest lameness prevalence (Burow et al., 2014).
Explanation
Objectives are the detailed aims of the study. Well-crafted
objectives specify populations, exposures and outcomes,
and parameters that will be estimated. They might be for-
mulated as specific hypotheses or as questions that the
study was designed to address. In some situations, objec-
tives might be less specific, for example in early discovery
phases. Regardless, the report should clearly reflect the
investigators’ original intentions.
3 (b). Ensure that the level of organization is clear for each
objective and hypothesis
Example
There were three objectives for this study: (1) to quantify the
standing and lying behavior, with particular emphasis on
post-milking standing time, of dairy cows milked 3 9 /d,
(2) to determine the cow- and herd-level factors associated
with lying behavior, and (3) to relate these findings to the
risk of experiencing an elevation in somatic cell count (SCC)
(Watters et al., 2013).
Explanation
A full explanation is provided in Box 4: Organization struc-
tures in animal populations
Methods
The aim of the methods section is to describe what
experiments were planned and performed in sufficient
detail for the reader to understand them; judge whether
they were adequate with respect to providing reliable,
valid answers to the objectives and hypotheses; and assess
whether deviations from the original research plan were
justified.
1In examples quoted directly from the literature, citations were removed
and replaced with [] to indicate that the statement was referenced in the
original document.
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Box 4
Organization structures in animal populations
Many animal populations occur in organizational structures, which results in individual animals (or groups of animals) not
being independent from one another (Schukken et al., 2003; Sargeant et al., 2010). These organizational structures might be
hierarchical, such as those related to housing (animals within barns, barns within farms, farms within production systems,
production systems within regions) or genetics (piglets within sows, calves within dams, daughters within sires). Animal
populations can also be non-independent but not hierarchical. For example, beef calves from several cow-calf farms might
be transported to multiple feedlots, where calves from multiple farms commingle in pens. Calves from the same farm or
housed in the same pen or feedlot probably have more exposures in common than calves at a different farm or in a differ-
ent pen or feedlot. Such organizational structures imply non-independence, which will influence the actual number of
observational units in the study and power in the statistical analyses. Therefore, the non-independence must be accounted
for in the study design or adjusted for in the data analysis (European Food Safety Authority, 2013).
Further, the study’s end-users might be interested in different hierarchy levels. Thus, it is essential that the authors clearly
state what level is being studied. For example, for a particular disease, producers and veterinarians might focus on the dis-
ease prevalence within herds and factors associated with individual risk of developing disease (Rose, 2001). However, com-
pany officials might be interested in the prevalence of positive herds within a production system and factors associated with
a herd being positive or with high or low prevalence (Rose, 2001). Government officials might concentrate on differences in
the prevalence of positive herds across regions of a country or among countries. It is also possible to report the outcomes
of interest at different organizational structure levels in a single study (Kadohira et al., 1997; McDermott et al., 1997; De
Vliegher et al., 2004). Given this complexity, authors must ensure that readers are aware of the organizational level(s) that
exist within the study population and the level at which variables are measured and summarized. This information allows
the reader to (i) decide if the paper is of interest and (ii) assess experimental approaches for biases, which might differ
based on the hierarchy level summarized. A diagram showing the organizational structure might be helpful to convey this
information.
The organizational structure is relevant to numerous parts of a publication. In particular, we advise providing information
about the study population’s organizational structure in items 3, 6, 7, 12, 13, 14 and 15. Here, we provide two study exam-
ples along with a description of how to report organization structures in items 3, 6, 7 and 12.
Example 1. A hypothetical multiclinic study of demographic factors affecting survival of dogs with osteosarcoma
Item 3 would describe the study objective: to understand demographic factors that impact a dog’s survival time. For this
theoretical example, the hypothesis is that dog age is associated with reduced survival time in individual dogs.
Item 5 would describe the clinics and clinicians participating in the study and indicate that they are a likely source of non-
independence.
Item 6 would describe the eligibility criteria for selecting clinics, clinicians and clients and dogs for the study.
Item 7 would define the outcome and other variables, as well as the organizational level for each variable. For this hypothet-
ical example, the measurement level for the outcome was at the individual level such as a dog’s survival time. The exposure
factors of interest were also at the individual level such as the dog age, dog weight and dog breed.
Item 8 would describe how each of the variables listed in item 7 was measured and state that all of these measurements
were performed at the individual level (the dog level).
Item 12 would describe how the analysis approach accounted for the impact of the organization structure such as dog non-
independence, nested within clinics and clinicians.Example 2. A hypothetical multifarm study of factors affecting the preva-
lence of Salmonella in swine barns
Item 3 would describe the study objective: to understand barn-, site- and company-level characteristics associated with the
prevalence of Salmonella in swine barns. In the example study, the hypothesis was that the prevalence of Salmonella is
higher in barns where birds are observed.
Item 5 would state that the pigs are nested within barns, the barns are nested within sites, and the sites within companies.
Other possible sources of non-independence (e.g. if farms are nested geographically) should also be stated.
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4. Study design: present key elements of study design early
in the paper
Example
A cohort study was performed on two farrow-to-finish
farms (A and B) in two farrowing rooms (cohorts) per
farm. Sows were examined for the presence of A. pleurop-
nemoniae infection by collection of blood and tonsil brush
samples approximately three weeks before parturition. The
proportions of colonization at litter and individual piglet
level were determined three days before weaning and asso-
ciations with dam parity and sow serum and brush sample
results were evaluated (Tobias et al., 2014).
Explanation
We advise presenting key elements of study design early
in the methods section (or at the end of the introduc-
tion) so that readers can understand the basics of the
study. For example, if the authors used a cohort study
design, which followed animals or animal groups over a
particular time period, they should describe the group
that comprised the cohort and their exposure status.
Similarly, if the investigation used a case–control design,
the cases and controls and their source population(s)
should be described.
If a study is a variant of the three main study types
(cohort, case–control or cross-sectional), there is an
additional need for clarity. Authors can provide a clear
description of the study design by including the follow-
ing key elements: (i) the timing of study population
enrolment with respect to the occurrence of the outcome
such as after or prior to, (ii) the role of exposure status
on enrolment such as enrolled based on exposure or
not, (iii) the role of outcome status on enrolment such
as enrolled based on outcome or not, (iv) the timing of
outcome and exposure determination such as outcome
determined before, after or concurrent to exposure deter-
mination and (v) if the outcome is a disease, condition or
behaviour, whether the outcome represents incidence or
prevalence. If the study only estimates prevalence or inci-
dence in a single group, then the authors need to clarify
whether the outcome represents incidence or prevalence.
This item is intended to give the reader a general idea of
the study design. The design specifics are described in
detail in subsequent items.
We recommend that authors refrain from calling a
study ‘prospective’ or ‘retrospective’ because these terms
are ill defined (Vandenbroucke, 1991). One usage sees
cohort and prospective as synonymous and reserves the
word retrospective for case–control studies. A second
usage distinguishes prospective and retrospective cohort
studies according to the timing of data collection relative
to when the idea for the study was developed (Miettinen,
1985). A third usage distinguishes prospective and retro-
spective case–control studies depending on whether the
data about the exposure of interest existed when cases
were selected (Rothman and Greenland, 1998).
In STROBE-Vet, we do not use the words prospective
and retrospective, nor alternatives such as concurrent and
historical. We recommend that whenever authors use these
Item 6 would describe the criteria for selecting the companies, the sites within each company, the barns within each site
and the pigs within each barn. It would include at what organizational levels, convenience sampling was used. For example,
in our hypothetical study, researchers used a relationship with a production company to gain access to a production site.
They also used convenience to decide which production sites to study and selected all barns on each site to be surveyed.
Then, they randomly selected 30 pigs within each barn to obtain barn-level estimates of Salmonella prevalence.
Item 7 would define the outcome and other variables, ensuring the organizational level is stated clearly. For this study, the
outcome of interest was the prevalence of Salmonella in each barn. The exposure variables of interest were feed type (a site-
level variable), and potential confounders included the feed mill used (a site-level variable) and the presence of birds in
barns (a barn-level variable).
Item 8 would describe how each of the variables defined in item 7 were measured. In this study, it would be important to
clarify that Salmonella status was measured in pigs (an individual-level variable) and the prevalence was summarized as a
proportion, so it could be expressed as a barn-level outcome. The laboratory approach for determining Salmonella status
should be described here. This item should state that data regarding the feed mills used at each site were obtained from
company records and the presence of birds was determined using a questionnaire administered to the site manager. The
validity of that questionnaire should be described as a component of this item.
Item 12 would describe how the analysis approach accounted for the organizational structure such as non-independence of
barns within farms, farms within regions, farms within the production system. Because the outcome was measured at the
barn level (as clarified in item 7), authors would need to account for the clustering of pigs within barns.
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words, they define what they mean. Most importantly, we
recommend that authors describe exactly how and when
data collection took place.
5 (a). Setting: describe the setting, locations and relevant
dates, including periods of recruitment, exposure, follow-
up and data collection
5 (b). If applicable, include information at each level of
organization
Example
This study was conducted in Afar and Tigray regions
in north-eastern Ethiopia. Two administrative zones
(Zone-1 and Zone-4) out of five zones of Afar region
were included in the study, and then one district from
each zone was selected (Asiyta and Yallo, respectively).
Asayita district was selected to include an agro-pastoral
production system where irrigation farming is widely
prevalent. . . . Yallo was selected for its location interfacing
with the highland agro-climate in Alamata and Raya
Azebo districts where the livestock are moved for grazing
and watering during dry season [ ]. There were two dis-
tinct agro-ecological climates prevailing in the Afar study
area: lowland (<1500 m) and highland (>2300 m). . . .
A cross-sectional study was carried out between October
2011 and February 2012 to assess epidemiological factors
associated with observed [lumpy skin disease] in the previ-
ous two years (September 2009 to October 2011). Three to
four Kebeles (the lowest administrative unit next to district
in order of hierarchy in Ethiopia) were selected randomly
from each district, and 20-30 herds were randomly selected
from each Kebele. Herd-owners were selected based on
willingness to complete the questionnaire (Hailu et al.,
2014).
Explanation
Readers must understand the clinical, demographic,
managerial, geographic and temporal contexts in which
the study was conducted, so readers will be able to
determine the populations to which the study’s infer-
ences can be applied. Data from research herds or ken-
nels might not extrapolate to commercial or home
settings. Dates are required to understand the historical
context of the research, because medical, sociological
and agricultural practices can change over time, which,
in turn, can affect the prevalence of risk factors, poten-
tial confounders, diseases and study methods. Knowing
when a study took place and over what period partici-
pants were recruited and followed places the study in
historical context and is important for the interpreta-
tion of results.
6. Participants
6 (a). Describe the eligibility criteria for the owners /
managers and for the animals, at each relevant level of
organization
Example
Counties were chosen based on the proportion of registered
backyard flock owners and location of commercial indus-
tries and auction markets. In May 2011, the Maryland
Department of Agriculture (MDA) confidentially mailed
1,000 informational letters and return postcards to poultry
owners enrolled in the Maryland Poultry Registration Pro-
gram. Participants were eligible for the study if they lived in
Maryland, owned domesticated fowl, and maintained a
flock size fewer than 1,000 birds (Madsen et al., 2013).
Explanation
Eligibility criteria might be presented as inclusion and
exclusion criteria, although this distinction is not always
necessary or useful. Regardless, we advise authors to report
all eligibility criteria and also to describe the group from
which the study population was selected (e.g. the general
population of a region or country), and the method of
recruitment (e.g. referral or self-selection through adver-
tisements). Authors of studies involving animal popula-
tions should describe the eligibility criteria at all
organizational levels (e.g. farm, pen, stable or clinic) for the
animals included, and for smaller units within included
animals, such as limbs or mammary quarters, if applicable
(see Box 4: Organization structures in animal populations).
6 (b). Describe the sources and methods of selection for
the owners/ managers and for the animals, at each relevant
level of organization
Example
All MRSP isolates identified between October 2010 and
October 2011 inclusive were considered. MSSP isolates were
selected throughout the study period using simple random-
ization on www.randomizer.org’ (Lehner et al., 2014).
Data and pedigree information were obtained from the
Swedish Dairy Association (Stockholm, Sweden), and the
Swedish organic certification organization (KRAV; Uppsala,
Sweden) contributed information about dairy farms with
organic plant production. . . . The initial data set contained
records from 402 organic herds (all herds with available
data) and 5,335 . . .. conventional herds (herds with an even
last number in the herd identity) (Ahlman et al., 2011).
Explanation
There are many ways eligible study units can be selected,
and when multiple organizational levels are used, the
© 2016 The Authors. Zoonoses and Public Health published by Blackwell Verlag GmbH8
STROBE-Vet Explanation and Elaboration A. M. O’Connor et al.
selection approach might differ based on the level. For
example, random selection might be used at one level and
convenience sampling at another. Clear and transparent
descriptions of the selection approach for eligible study
units enable identification of the population to which the
study results can be inferred and any potential selection
biases. When non-probability sampling (e.g. convenience,
haphazard or snowball methods) is used, indicate this
explicitly and provide a rationale for its use.
6 (c). Describe the method of follow-up
Example 1
After surgery, the owners of the dogs were instructed to
monitor for any signs of new mammary tumors and notify
the principal investigator (PI) if any signs of recurrence or
new tumors were noted. In addition, they were contacted
by the PI (VK) every 6 months through phone to ensure
this information. . . . Dogs with reported/ suspected new
tumors were requested to return for clinical examination
and confirmation (Kristiansen et al., 2013).
Example 2
Table 1 Possible outcomes of horses on cohort
Possible outcome Action
No further colic during study Censored
Colic resolves without medication Horse returns to population at
risk 48 h after colic episode
Colic requires medical attention –
clinical records obtained
Horse returns to population at
risk 48 h after colic episode
Colic requires surgery Surgical diagnosis and end of
contribution to time at risk
Death from other causes Censored
Drop out of cohort Censored/loss to follow-up
(Scantlebury et al., 2011)
Explanation
The potential for loss to follow-up differs between studies;
therefore, follow-up monitoring approaches might differ
between studies. For example, companion animal popula-
tions that rely on client return visits are prone to loss to fol-
low-up, analogous to the human population studies
discussed in STROBE. The authors of these studies often
make several attempts to contact animal owners to deter-
mine their pet’s outcome. In other animal populations,
data might be collected from computerized systems, such
as herd inventory at the start and end of the study, where
relevant records (e.g. the reasons for losses) might or might
not be available. Reporting the approach used by the
authors to minimize loss to follow-up will allow users to
assess the potential for bias related to this loss.
6 (d). For matched studies, describe matching criteria and
number of matched individuals per subject (e.g. number
of controls per case)
Example 1
Two to 4 control farms matched to each case farm on the
basis of type of farm (dairy or beef) and location (inside or
outside the TB core area) were included in the study.
(Kaneene et al., 2002)
Example 2
Each time a herd was recorded as a “case,” a randomly
selected at-risk herd was identified as a “control”. Each
control herd was selected with probability proportional to
their time at risk (incidence density sampling) during the
study period. . . (Olea-Popelka et al., 2006).
Explanation
Matching is more common in case–control studies, but
occasionally, investigators use matching in cohort stud-
ies. Matching in cohort studies makes groups directly
comparable for potential confounders (Box 5: Confound-
ing) and presents fewer intricacies than with case–con-
trol studies. For example, it is not necessary to take the
matching into account for the estimation of the relative
risk. Because matching in cohort studies might increase
statistical precision, investigators might allow for the
matching in their analyses and thus obtain narrower
confidence intervals.
In case–control studies, matching is done to increase a
study’s efficiency by ensuring similarity in the distribution
of variables between cases and controls, in particular the
distribution of potential confounding variables (Costanza,
1995; Sturmer and Brenner, 2002). Example 1 illustrates
this type of matching description by matching on farm type
and location. Because matching can be done in various
ways, with one or more controls per case, the rationale for
the choice of matching variables and the details of the
method used should be described. Commonly used forms
of matching are frequency matching (also called group
matching) and individual matching. In frequency match-
ing, investigators choose controls so that the distribution of
matching variables becomes identical or similar to that of
cases. Individual matching involves matching one or several
controls to each case. Matching is not always appropriate
in case–control studies, but if used, it needs to be taken into
account in the analysis (see Box 2: Matching in case–con-
trol studies).
While matching is generally considered to be based on
potentially confounding population characteristics, in some
case–control studies, the term matching is also used to
describe a means of controlling selection from the risk set
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based on the case occurrence timing such as in an incidence
density sampling design. Example 2 provides a description
of a time-matched selection-control approach.
7 (a). Clearly define all outcomes, exposures, predictors,
potential confounders and effect modifiers. If applicable,
give diagnostic criteria
Example 1
. . .the explanatory variable of interest was IBK status. Other
explanatory variables included in each model as potential
effect modifiers or confounders of the association between
IBK and weight at ultrasonographic evaluation were birth
weight, season, sex of calves after weaning (bull, heifer, or
steer), ADG (weaning to yearling weight), preweaning
management group, postweaning management group, year
of calving, season of calving, the interaction between year
and season, and age at ultrasonographic evaluation (Funk
et al., 2014).
Example 2
Refer to Section 6(c) for a good description of the outcome
event(s) in a cohort study.
Example 3
Body condition was scored from 1 (emaciated) to 5 (obese)
using standard methods described by DAFF []. Faecal con-
sistency was scored as described by Alberta Dairy Manage-
ment [] from 1, representing a liquid consistency, to 4,
representing a dry sample. Hide cleanliness was scored fol-
lowing the guidelines of the Food Standards Agency [],
where 1 = clean and dry, and 5 = filthy and wet (Williams
et al., 2015).
Explanation
Authors should define all variables considered for and
included in the analysis, including outcomes, exposures,
Box 5
Confounding
Confounding literally means the confusion of effects. A study might seem to show either an association or no association
between an exposure and the risk of a disease. In reality, the seeming association or lack of association is due to another
factor that determines the occurrence of the disease but that is also associated with the exposure. The other factor is called
the confounding factor or confounder. Confounding thus gives a wrong assessment of the potential ‘causal’ association of
an exposure. For example, an apparent positive association between dogs attending obedience classes and dog bites could
occur if specific, large-breed dogs that are prone to biting were more likely to attend the observed obedience classes. In this
instance, breed would confound the relationship between obedience class attendance and biting.
Investigators should think beforehand about potential confounding factors, a process that could be enhanced by construct-
ing a causal diagram (see item 7c). An a priori consideration of potential confounding variables will inform the study
design and allow proper data collection by identifying the confounders for which detailed information should be sought.
Restriction, matching or analytical adjustment might also control confounding. In the example above, the study might be
restricted to specific breeds. Matching on breed might also be possible, although not necessarily desirable (see Box 2:
Matching in case–control studies). There are a number of analytic approaches for identifying confounding variables, which
can be broadly grouped into knowledge-based and statistical (Evans et al., 2012; Sauer et al., 2013).
Many of the approaches for controlling confounding assume that the investigator has one or more exposures of interest
identified a priori. In veterinary literature, observational studies commonly identify risk factors for an outcome from an
array of possible independent variables with no a priori identification of an exposure of interest or causal diagram.
Regardless of the approach used, when variables are selected for model inclusion, the interpretation of each association
needs to be evaluated post hoc to evaluate whether all important confounders for that association were included. As part of
the post hoc assessment, authors should consider whether the variables were confounders or variables with other relation-
ships, such as collider or intervening variables. These other variables can also introduce bias into the association between a
different independent variable and the outcome and be detected by algorithm-based approaches (Greenland and Brumback,
2002; Hernan et al., 2002; Schisterman et al., 2009; Hay et al., 2014).
Taking confounders into account is crucial in observational studies, but readers should not assume that analyses adjusted
for confounders establish the ‘causal part’ of an association. Results might still be distorted by residual confounding (the
confounding that remains after unsuccessful attempts to control for it), (Olsen and Basso, 1999) random sampling error,
selection bias and information bias (see Box 1: Bias in observational studies).
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predictors, potential confounders and potential effect mod-
ifiers. Disease outcomes require adequately detailed
description of the diagnostic criteria. This applies to criteria
for cases in a case–control study, disease events during
follow-up in a cohort study and prevalent disease in a
cross-sectional study.
We advise that authors should declare all ‘candidate vari-
ables’ considered for statistical analysis, rather than selec-
tively reporting only those included in the final models (see
also item 16a) (Anderson et al., 2005; Wieland and Dick-
ersin, 2005). Authors should report whether exposures are
consistent or change over the study period. For studies
involving follow-up, authors should describe how study
subjects were uniquely identified, allowing research person-
nel to correctly record observations at follow-up visits.
7 (b). Describe the level of organization at which each
variable was measured
Example
Fixed explanatory variables considered for inclusion in the
PA-MNT model were assessment day (d –4, +1, +3, +6, +8,
and +10), eye-level IBK-associated corneal ulceration status
(present or absent), calf-level IBK-associated corneal ulcer-
ation status (present or absent), and landmark (7 levels)
(Dewell et al., 2014).
Explanation
Animal populations commonly have multiple organiza-
tional levels, so authors should clarify the organizational
level at which each variable was measured. For more infor-
mation, see Box 4: Organization structures in animal
populations.
7 (c). For hypothesis-driven studies, the putative causal
structure among variables should be described (a diagram
is strongly encouraged)
Example
Causal diagrams were constructed to describe postulated
links between measured exposure variables and between
exposure variables and occurrence of BRD in the first
50 days at risk. As this resulted in a very complex diagram, a
Box 2
Matching in case–control studies
In any case–control study, choices need to be made on whether to use matching of controls to cases, and if so, what vari-
ables to match on, the precise method of matching to use, and the appropriate method of statistical analysis. Although con-
founding can be adjusted for in the analysis there could be a major loss in statistical efficiency. The use of matching in
case–control studies and its interpretation are fraught with difficulties, especially if matching is attempted on several risk
factors, some of which might be linked to the exposure of prime interest (Rothman and Greenland, 1998; Szklo and Nieto,
2000). For example, in a case–control study of a Salmonella outbreak, investigators could match based on factors, such as
gender, that are related to the consumption of various food products. However, this control group would no longer repre-
sent food consumption choices in the general population, and has several implications. A crude analysis of the data will
produce odds ratios that are usually biased towards unity if the matching factor is associated with the exposure. The solu-
tion is to perform a matched or stratified analysis (see item 12d). In addition, because the matched control group ceases to
be representative for the population at large, the exposure distribution among the controls can no longer be used to esti-
mate the population attributable fraction (see Box 6: Measures of Association and measures of impact) (Cole and MacMa-
hon, 1971). Also, the effect of the matching factor can no longer be studied. If matching is done on multiple factors, the
search for well-matched controls can be cumbersome and a non-matched control group might be preferable.
Overmatching is another problem, which might reduce the efficiency of matched case–control studies and, in some situa-
tions, introduce bias.
Information is lost and the power of the study is reduced if the matching variable is closely associated with the exposure.
Then many individuals in the same matched sets will tend to have identical or similar levels of exposures and therefore not
contribute relevant information.
The complexities involved with matching have caused some methodologists to advise against routine matching in case–con-
trol studies. Instead, they recommend judicious consideration of each potential matching factor, recognizing that it could
potentially be measured and used as an adjustment variable. As a result, studies are reducing the number of matching fac-
tors employed, and increasing the use of frequency matching, which avoids some of the problems discussed above. In addi-
tion, case–control studies are increasingly abandoning potential confounder matching (Gefeller et al., 1998). Currently,
matching remains advisable, or even necessary, when confounder distributions differ radically between the unmatched com-
parison groups (e.g. age) (Costanza, 1995; Sturmer and Brenner, 2002).
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simplified version (only including variables relevant to the
assessment of the risk factors included in the analyses
reported in this paper) is shown in Fig. 1. Figure 2 shows the
causal diagram used to inform the analyses restricted to the
three feedlots that routinely used pre-induction assembly.
Additional variables included as potential confounders in
either of these diagrams were cohort fill duration (all
animals added to their cohort within a single day or over a
longer period), total number of animals on feed in the
animal’s feedlot (average for the animal’s induction month),
number of animals in the animal’s cohort, induction weight,
breed and season in which the animal was inducted. . . .The
DAGitty software [] was used to identify minimal sufficient
adjustment sets to assess total and direct effects of the
exposure variable of interest on the occurrence of BRD.
Figures extracted from publication(Hay et al., 2014)
Fig. 1 Causal diagram showing postulated causal paths linking variables related to mixing history, group size, exposure to saleyards 
and timing of the move to the feedlot to occurrence of bovine respiratory disease (BRD) in the first 50 days on feed.
K.E. Hay , T.S. Barnes , J.M. Morton , A.C.A. Clements , T.J. Mahony 
Risk factors for bovine respiratory disease in Australian feedlot cattle: Use of a causal diagram-informed approach to
estimate effects of animal mixing and movements before feedlot entry
Preventive Veterinary Medicine, Volume 117, Issue 1, 2014, 160 - 169
http://dx.doi.org/10.1016/j.prevetmed.2014.07.001
Fig. 2 Causal diagram showing postulated causal paths linking variables related to the interval between arrival and induction, group
size and number of groups combined to occurrence of bovine respiratory disease (BRD) in the first 50 days on feed in three ...
K.E. Hay , T.S. Barnes , J.M. Morton , A.C.A. Clements , T.J. Mahony 
Risk factors for bovine respiratory disease in Australian feedlot cattle: Use of a causal diagram-informed approach to
estimate effects of animal mixing and movements before feedlot entry
Preventive Veterinary Medicine, Volume 117, Issue 1, 2014, 160 - 169
http://dx.doi.org/10.1016/j.prevetmed.2014.07.001
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Explanation
For hypothesis-driven studies, it is extremely useful to the
end-user if the a priori hypothesis and the variable relation-
ships envisioned by the authors are clear and understand-
able. There are various means available for articulating
causal assumptions (Greenland and Brumback, 2002),
including directed acyclic graphs (DAGs) (Greenland et al.,
1999). Including a causal assumption diagram is strongly
recommended. Understanding the underlying causality
being explored is important when identifying potential
confounding variables and interpreting the results of multi-
variable analyses. If variables are controlled unnecessarily in
a regression model, the power is reduced, and the associa-
tion between the exposure of interest and the outcome
might be biased (Greenland and Brumback, 2002; Hernan
et al., 2002; Schisterman et al., 2009).
8 (a). For each variable of interest, give sources of data
and details of methods of assessment (measurement). If
applicable, describe comparability of assessment methods
among groups and over time
Example
Each tumour was examined independently by two specialist
veterinary pathologists and, to be included, had to have a
minimum of 7 (out of a possible 10) features identified as
part of the histopathology study. The 10 features included
the presence of: aggregates of lymphocytes, infiltrative mar-
gins, intralesional necrosis, perilesional scarring,/inflamma-
tion, adjuvant-like material in macrophages, medium-high
mitotic rate, giant cells and types of cellular differentiation
[]. To be included in the estimate of incidence the FISS
(“Feline Injection Site Sarcomas” added by authors) had to
be diagnosed at the practices for which denominator
information was available (Dean et al., 2013).
Explanation
The way in which exposures, confounders and outcomes
were measured affects the reliability and validity of a study.
Measurement error and misclassification of exposures or
outcomes can make it more difficult to detect cause–effect
relationships, or might produce spurious relationships.
Error in measurement of potential confounders can
increase the risk of residual confounding (Becher, 1992;
Brenner and Blettner, 1997). It is helpful, therefore, if
authors report the findings of any studies of the validity or
reliability of assessments or measurements, including
details of the reference standard that was used. Rather than
simply citing validation studies, we advise that authors give
the estimated validity or reliability, which can then be used
for measurement error adjustment or sensitivity analyses
(see items 12 and 17).
In addition, it is important to know whether groups
being compared differed with respect to the way in which
the data were collected. For instance, if an interviewer first
questions all the cases and then the controls, or vice versa,
bias is possible because of the learning curve; solutions such
as randomizing the order of interviewing might avoid this
problem. Information bias might also arise if the compared
groups are not given the same diagnostic
8 (b). If a questionnaire was used to collect data, describe
its development, validation and administration
Example
Questionnaire designs were the collective effort of five
veterinarians (including four epidemiologists) and a bio-
statistician. Included in the design group was the Veterinary
Officer for Poultry Diseases, who had an in-depth knowl-
edge of each farm as a result of working with the producers
to eradicate Salmonella from poultry. There were several
questionnaires, the main one designed to record indepen-
dent variables acting at the various levels of broiler produc-
tion such as at the flock, house and farm levels. During the
interval between flocks in each broiler house, a field techni-
cian employed by the Veterinary Officer for Poultry Diseases
visited each farm to record responses from face-to-face
interviews with the person most closely associated with the
hands-on management of the broiler flocks and houses, and
to record observations of cleaning and disinfection proce-
dures between flocks. The design team reviewed all ques-
tions and the method of recording with the field technician
to ensure clear understanding. The Veterinary Officer for
Poultry Diseases accompanied the field technician on all farm
visits and questionnaire recording for the first full month of
sampling. During the course of the study, two university-edu-
cated field technicians were employed. The first technician was
employed for two years, and trained the second technician for
one month prior to leaving the project. Interview times varied
from 10 to 15 minutes per questionnaire, depending on
whether the producer needed to verify records. To ensure con-
sistency in responses, data collected at the previous visit were
reviewed with the producer. All questions pertaining to our
analysis were closed (Guerin et al., 2007).
Explanation
For STROBE-VET, we needed to draw attention to the
descriptions of questionnaire development and adminis-
tration, because questionnaires are a common data
source for veterinary observational studies. Occasionally,
authors provide information documenting their ques-
tionnaire validation methods, sometimes as a separate
publication (Ramon et al., 2008; Dufour et al., 2010). If
previous validation information is not available, then
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the authors should describe their approach for develop-
ing and testing the questionnaire in the manuscript.
Like any diagnostic test, unless validated, the diagnostic
characteristics of the questionnaire and its ability to
accurately measure the variables are unclear. The ques-
tionnaire(s) should also be included as supplementary
data, or in an open access, permanent site preferably
with a Digital Object Identifier (DOI).
8 (c). Describe whether or not individuals involved in data
collection were blinded, when applicable
Example
This was an observational study of 292 uniquely identified
Bovelder cows born in either 2002 or 2003 (2002 and 2003
cohorts) that were followed from just prior to their first
breeding season until they had weaned up to five calves. . . .
Farm management and staff were blinded to RTS (repro-
ductive tract scoring) data throughout the study (Holm
et al., 2015).
Explanation
While blinding is commonly associated with randomized
controlled trials, in observational studies, there is poten-
tial for information bias in measurement of exposure
arising from knowledge of the outcome of interest (case–
control studies) or information bias in measurement of
the outcome arising for knowledge of the exposure of
interest (cohort studies) (O’Connor et al., 2010; Sargeant
et al., 2010). For example, if researchers conduct a case–
control study determining factors associated with a tick-
borne disease such as Lyme disease (the outcome of
interest) and an owner is interviewed about indoor or
outdoor exercise (the exposure of interest), the owners
of case animals might recall outdoor exercise more
easily, because they are familiar with the disease and its
causes. This prior knowledge is a potential source of
bias. Thus, information about blinding is critical for the
reader to assess the impact of bias on the study result.
Similar to clinical trials, the use of the terms single- and
double blinding should be avoided. Rather, the author
should specify the task, caregiver or outcome assessor
who is blinded (Giuffrida et al., 2012).
8 (d). Describe any efforts to assess the accuracy of the
data (including methods used for ‘data cleaning’ in
primary research, or methods used for validating
secondary data)
Example
Selections of dogs from the entire hospital records were
made using Oracle programming languages . . . []. First, an
in-house hospital code for laboratory-confirmed diagnosis
of urolithiasis was used to isolate all the eligible dogs within
the boundaries of the study population. . . . Afterwards,
urolith laboratory results or medical notes of the identified
dogs were manually reviewed to isolate those whose urolith
composed of at least 70% monohydrate or dehydrate forms
of CaOx (case dogs). Urolith composition was determined
at one of two commercial laboratories . . . by means of opti-
cal crystallography or infrared spectroscopy as described
elsewhere [] (Okafor et al., 2014).
Explanation
Reporting the measurement approach is frequently insuffi-
cient to ensure validity; therefore, when efforts are made to
ensure the data are valid (e.g. the case validity in the exam-
ple above), these methods should be documented. This
documentation enables the end-user to identify potential
information bias. In the example above, there could have
been concern that the electronic medical records were inac-
curate; therefore, the authors validated the electronic medi-
cal records by examining the physical medical records,
giving the end-user greater confidence in the variable mea-
sured. In addition, when data are used for multiple different
studies, the data could have been collected for a different
purpose initially than that described in the later study. In
this case, the original purpose should be described. A
description of data validation approaches has recently been
published (Emanuelson and Egenvall, 2014).
Bias: describe any efforts to address potential sources of
bias due to confounding, selection or information bias
Example
The responses were collected through face-to-face inter-
views conducted by four experienced interviewers (two
teams each comprising two interviewers) between October
2011 and March 2012. As there are different dialects in the
Philippines, the questionnaire was written in English and
translated to the appropriate dialect at the interview. To
reduce information bias the questionnaire was pretested on
experts in the Philippines pig production systems compris-
ing regional and provincial veterinary officers and animal
health advisors. All questions in the questionnaire were
clarified with all interviewers before the study date. The
interviewers were instructed to ask questions exactly as sta-
ted in the questionnaire and provide only non-directive
guidance. To minimize inter-observer variability in con-
ducting the interview, all observers and PVO [Provincial
Veterinary Office] personnel met after the questionnaire
was piloted on the six farms to agree on a common inter-
pretation of the findings. If there was disagreement, the
interpretation of the PVO was chosen. To minimize infor-
mation (misclassification) and selection biases, the
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interviewers were asked to verify the trader’s identity, dates
when the pigs were sold and number of pigs sold for
slaughter before an interview was conducted. . . . The valid-
ity of the collected questionnaire data was confirmed dur-
ing follow-up visits to six farms (three in each province) by
the first author, the interviewers and Provincial Veterinary
Officers personnel. To reduce misclassification bias that
could arise from coding errors, the interviewers and the
first author checked and corrected impossible coding of
categorical variables (n = 80) and unreliable outlier values
for continuous variables (n = 3) (Alawneh et al., 2014).
Explanation
Bias causes study results to differ systematically from the
truth. It is important for a reader to know what measures
were taken during the conduct of a study to reduce the
potential of bias. Ideally, investigators carefully consider
potential sources of bias when they plan their study. At the
stage of reporting, we recommend that authors always assess
the likelihood of relevant biases. Specifically, the direction
and magnitude of bias should be discussed and, if possible,
estimated. When investigators have set up quality control
programmes for data collection to counter a possible ‘drift’
inmeasurements of variables in longitudinal studies, or to keep
variability at a minimum when multiple observers are used,
these should be described. In veterinary medicine, euthanasia
or animal culling is a unique potential form of attrition bias,
and authors should describe any methods used to account for
this bias. Recently, an overview of approaches for addressing
bias, including quantitative bias analysis and the use of bias
parameters in data analysis, with accompanying veterinary
examples was published (Dohoo, 2014).
A discussion about selection bias, information bias and
confounding as well as their impact on observational stud-
ies is provided in Box 1: Bias in observational studies and
Box 5: Confounding .
10 (a). Study size: describe how the study size was arrived
at for each relevant level of organization
Example
A sample size of 36 cases and 108 controls was calcu-
lated to provide a 95% level of confidence for detecting
an odds ratio of 3 with 80% statistical power, assuming
a 1:3 ratio of case to control farmers and a random
notification process such as a 50% probability of report-
ing observed oyster mortality. Sample size was increased
by 15% to account for non-participation rate observed
in previous and recent studies conducted in the same
population [], leading to a total of 41 cases and 124
controls, out of 165 and 703 eligible oyster farmers,
respectively (Lupo et al., 2014).
Explanation
A study should be large enough to obtain a point estimate
with a sufficiently narrow confidence interval to meaning-
fully answer a research question. Large samples are needed
to distinguish a small association from no association. Small
studies often provide valuable information, but wide confi-
dence intervals might indicate that they contribute less to
current knowledge in comparison with studies providing
Box 1
Bias in observational studies
Bias is a systematic deviation of a study’s results from a
true value. Typically, it is introduced during the design
or implementation of a study and its effects cannot be
eliminated later or correct analytically. Bias and con-
founding are not synonymous. Bias arises from flawed
information or subject selection so that a wrong associa-
tion is found. Confounding produces relations that are
factually correct, but they cannot be interpreted causally
because some underlying, unaccounted for factor is asso-
ciated with both exposure and outcome (see Box 5: Con-
founding). Bias differs from random or chance error such
as a deviation from a true value caused by random fluc-
tuations in the measured data in either direction. Many
potential sources of bias have been described and a vari-
ous terms have been used (Sackett, 1979). We find that it
is helpful to separate them into two simple categories:
information bias and selection bias.
Information bias occurs when systematic differences in
data completeness or accuracy lead to animal misclassifi-
cation with respect to exposures, outcomes or measure-
ment errors of values recorded on a continuous scale.
Detection bias in cohort studies, interviewer bias and
recall bias are all forms of information bias. For example,
in a case–control study of risk factors for horse falls, poor
dressage performers were less likely to report accurate
dressage scores than good performers, thereby introduc-
ing information bias (Murray et al., 2004).
Selection bias exists when the association between the
exposure and outcome among study-eligible participants
is different from those participants included at any stage
of the study, from entry to the study to inclusion in the
analysis. Various types of selection bias include bias
introduced when selecting the control group in a case–
control study, differential loss to follow-up, incidence–
prevalence bias, volunteer bias, healthy worker bias and
non-response bias (Hernan et al., 2004). Detection bias
also acts as a form of selection bias in case–control stud-
ies (Dohoo et al., 2009).
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estimates with narrower confidence intervals. Also, small
studies that show ‘interesting’ or ‘statistically significant’
associations are published more frequently than small
studies that do not have ‘significant’ findings. While these
studies might provide an early signal in the context of
discovery, readers should be informed of their potential
weaknesses.
The importance of sample size determination in obser-
vational studies depends on the context. If an analysis is
performed on data that were already available for other
purposes, the main question is whether the analysis of
the data will produce results with sufficient statistical pre-
cision to contribute substantially to the literature. Formal
a priori calculation of sample size might be useful when
planning a new study (Rigby and Vail, 1998; Carlin and
Doyle, 2002). Such calculations are associated with more
uncertainty than implied by the single number that is
generally produced. For example, estimates of the rate of
the event of interest or other assumptions central to cal-
culations are commonly imprecise, if not guesswork
(Schulz and Grimes, 2005). The precision obtained in the
final analysis can often not be determined beforehand
because it will be reduced by inclusion of confounding
variables in multivariable analyses (Drescher et al., 1990),
the degree of precision with which key variables can be
measured, and the exclusion or non-selection of some
individuals (Devine and Smith, 1998).
Sample size determination can be complicated further by
studies with multiple objectives. Studies frequently have
multiple objectives, largely to maximize the amount of data
that can be collected from a research study. For instance, a
cross-sectional study might estimate an outcome frequency
and evaluate the association between one or more expo-
sures on that outcome. It should be clear to the reader
which objective was used for sample size determination or,
if both objectives were considered, how the final sample
size was derived.
In animal health, observational studies might not be
hypothesis driven. These studies are not conducted to
detect a specific effect size magnitude for an a priori iden-
tified exposure of interest. Instead, a large number of
association measures are calculated with varying levels of
precision. This type of study is hypothesis generating.
This factor should be discussed specifically, and the ratio-
nale for the sample size should be provided. Often, stud-
ies do not use formal sample size calculations. For
example, when a small number of cases are available for a
case–control study, the investigators might choose to
include all eligible cases. In this case, the reader still needs
to understand how the sample size was derived such as
selection of all available cases to evaluate the potential for
selection bias or identify an underpowered study.
10 (b). Describe how non-independence of measurements
was incorporated into sample size considerations, if
applicable
Example 1
The expected prevalence of MRSA was estimated to be
considerably lower at 1–2% [], with a much lower
between cluster T variance estimated at 0.0001, meaning
a total of 800 nasal swab samples would be required to
estimate prevalence with a precision of 1% and 95%
confidence. To allow for an overall compliance propor-
tion of approximately 60%, each practice was asked to
recruit the next 20 horses seen on visits (a total of
1300 horses) (Maddox et al., 2012).
Example 2
Researchers adjusted this sample size16 for clustering of
stillbirth risk in a herd by using the formula n* = n[1 + (m
 1)q], where m is the average herd size, q is the intra-class
correlation coefficient (ICC), and n is the unadjusted sam-
ple size necessary to determine the difference between 2
proportions.15 Expected herd size was approximately 150
cows and the ICC was estimated to be q = 0.09 (Waldner,
2008).
Explanation
Given the frequency of non-independent study units in
animal populations (see Box 4: Organization structures in
animal populations), authors should adjust sample size
calculations to account for non-independence. Failure to
account for non-independence in sample size determina-
tions might result in studies that are underpowered when
analysed correctly using methods that account for cluster-
ing. The ethics of conducting underpowered studies are
less obvious for observational studies, because study units
are observed rather than purposefully assigned to a group.
However, resources are potentially wasted when studies are
underpowered; therefore, adjustment for non-indepen-
dence in sample size determinations should be conducted
for prospectively planned observational studies.
10 (c). If a formal sample size calculation was used,
describe the parameters, assumptions, and methods that
were used, including a justification for the effect size
selected
Example
. . .prior to conducting the analysis, sample size calculations
were performed to determine whether it was likely to
obtain a data set of sufficient size to detect a difference of
7.5 kg (16.5 lb) in the primary outcome, live weight, in a
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population with 33% of calves in the IBK group and 67%
in the unaffected group, with a type I error probability of
0.05, a type II error probability of 0.8, and a 1:2 ratio for
case and control calves. The rationale for use of these
parameters was that results of a prior study suggested that
calves with IBK weighed approximately 7.5 kg less at wean-
ing than unaffected calves, and the prevalence of IBK was
approximately 33% in the study herd (Funk et al., 2014).
Explanation
Samples sizes should be calculated based on realistic esti-
mates. While statistical power can be determined using the
effect estimate precision and low power affects precision
not bias, providing the rationale and assumptions used in
the calculations allows the reader to infer the impact of
those assumptions on the sample size. For example, what
constitutes a meaningful difference might vary between dif-
ferent regions, and the assumed level of non-independence
can vary between populations.
11. Quantitative variables: explain how quantitative
variables were handled in the analyses. If applicable,
describe which groupings were chosen, and why
Examples
Age was grouped on a biological basis into less than
2.5 years, between 2.5 and 4.5 years and more than
4.5 years. This categorisation was decided upon as 2.5 and
4.5 years approximately coincide with ages at first and sec-
ond parturition in llamas (Rooney et al., 2014).
Explanation
Investigators make choices regarding how to collect and
analyse quantitative data about exposures, effect modifiers
and confounders. Grouping choices might have important
consequences for later analyses (Altman et al., 1994; Roys-
ton et al., 2006). We advise that authors explain why and
how they grouped quantitative data, including the number
of categories, the cut points and category mean or median
values (as appropriate). Whenever data are reported in
tabular form, the counts of cases, non-cases or controls,
animals at risk, animal-time at risk, etc. should be given
for each category. Tables should not consist solely of
effect-measure estimates or results of model fitting.
Authors should state whether categories were selected a
priori or based on the collected data.
>Investigators might model an exposure as continuous
to retain all the information. In making this choice, one
needs to consider the nature of the relationship of the
exposure to the outcome. Investigators should report how
departures from linearity were investigated (e.g. using log
transformation, quadratic terms or spline functions).
Several methods exist for fitting a nonlinear relation
between the exposure and outcome (Greenland, 1995;
Royston et al., 1999, 2006). Also, it might be informative to
present both continuous and grouped analyses for a quanti-
tative exposure of prime interest.
12. Statistical methods
12 (a). Describe all statistical methods for each objective,
at a level of detail sufficient for a knowledgeable reader to
replicate the methods. Include a description of the
approaches to variable selection, control of confounding
and methods used to control for non-independence of
observations
Example 1
Collinearity between the variables was investigated by v2
analysis. The risk factors initially offered to the model were
excluded from the model with a conditional backward elimi-
nation procedure; the possible interaction terms were then
investigated with a forward conditional selection procedure.
A factor was entered in the model at p ≤ 0.05 and removed
at p ≥ 0.10. The likelihood ratio test was used to assess the
overall significance of the model (two-tailed significance
level p ≤ 0.05). Confounding was monitored by evaluating
the change in the coefficient of a factor after removing
another factor; if the change exceeds 25% of the coefficient
value, the removed factor is considered a potential con-
founder. The significance of each term in the model was
tested by Wald’s v 2. In the final model, biologically plausible
interaction between factors was investigated by significance.
Estimated OR and 95%Wald’s confidence interval (CI) were
obtained as measures of predictor effect (Rizzo et al., 2016).
Example 2
To account for the hierarchical structure of the data, a cross-
classification of feedlot-years (11 feedlots in 2000, 13 in
2001–2002. . .) was included as a random intercept to model
the overdispersion arising from the lack of independence
of cohorts nested within feedlots, and of feedlots nested
within arrival years. In addition, arrival month . . . was mod-
eled as a random intercept using a first-order autoregressive
covariance structure to account for the repeated measures of
cohorts, within feedlot-years, over months with decay in cor-
relation with increasing distance between observations []
Lastly, arrival week . . . within a month was modeled as a
random intercept to control for the correlation of
weeks within arrival months (Babcock et al., 2013).
Explanation
Describing statistical methods can be challenging, because
the level of detail sufficient for a knowledgeable reader to
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replicate the methods is open to interpretation2 . The author
should focus on clearly describing the approach rather than
listing statistical tests. Inclusion of a diagram or flow chart
to explain a complex analytical process might be helpful.
One applicable resource for reporting statistical methods
are the SAMPL guidelines (Lang and Altman, 2013). Based
on the SAMPL guidelines, the description of the analysis
approach can be split into three components: (i) the prelim-
inary analysis, (ii) the primary analysis and (iii) any supple-
mentary analysis. Authors are encouraged to make the data
and their software coding available as supplementary mate-
rial or in data depositories.
In general, there is no one correct statistical analysis but,
rather, several possibilities that might address the same
question, but make different assumptions. Regardless,
investigators should predetermine analyses at least for the
primary study objectives in a study protocol. Often addi-
tional analyses are needed, either instead of, or as well as,
those originally envisaged, and these might sometimes be
motivated by the data. Authors should tell readers whether
particular analyses were suggested by data inspection. Even
though the distinction between pre-specified and explora-
tory analyses might sometimes be blurred, authors should
clarify reasons for particular analyses.
Authors should explain all potential confounders con-
sidered, and the criteria for excluding or including variables
in statistical models. Decisions about excluding or includ-
ing variables should be guided by knowledge, or explicit
assumptions, on causal relations. Inappropriate decisions
might introduce bias, for example by including variables
that are in the causal pathway between exposure and dis-
ease (unless the aim is to assess how much of the effect is
carried by the intermediary variable). If the decision to
include a variable in the model was based on the change in
the estimate, it is important to report what change was
considered sufficiently important to justify its inclusion. If
an algorithm such as ‘backward elimination’ or ‘forward
inclusion’ was used, report the process (including whether
a manual or automated process was used) and the signifi-
cance level and test or other basis (information criteria) for
selecting inclusion or exclusion of variable(s) from the
model.
12 (b). Describe the rationale for examining subgroups
and interactions and the methods used
Example
Biologically important two-way interactions of the explana-
tory variables in the final model were examined and
retained if significant (p < 0.05) (Schemann et al., 2011).
Explanation
Subgroup analyses and interactions can be planned or con-
ducted after reviewing the data. Authors should report if
the subgroup analysis was pre-planned or informed by data
examination. This information allows the end-user to iden-
tify the presented associations in the context of hypothesis
testing or hypothesis generating.
12 (c). Explain how missing data were addressed
Examples
In model 1, only subjects with complete information on vari-
ables in the final model were included. Model 2 was a Baye-
sian full-likelihood analysis where missing data were taken
into account and became a multidimensional additional
parameter [] (Rossow et al., 2014).
Explanation
Missing data are common in observational research. Ques-
tionnaires are not always filled in completely, owners might
not bring their animal to all follow-up visits and routine
data sources and clinical databases are often incomplete.
For analyses that account for missing data, authors should
describe the nature of the analysis (e.g. multiple imputa-
tion) and the assumptions that were made (See Box 7:
Missing data: problems and possible solutions).
In cases where euthanized or culled animals are desig-
nated as missing data or observations lost to follow-up in
the analysis, the authors should clearly identify this crite-
rion as a cause of missing data. Describing this aspect of
the analysis is important, because the circumstances sur-
rounding culling or euthanasia are likely not to be random,
which violates the assumption that the missing data are
random. The approach for reporting missing observations
or loss to follow-up is discussed in item 13.
12 (d). If applicable, describe the analytical approach to
loss to follow-up, matching, complex sampling and
multiplicity of analyses
Example
Conditional logistic regression [] was used to assess differ-
ences in mean production (3.5% FCM, fat, protein, LSCC),
JD test status as adults, removal from herd during the
observation period, and JD test status of dam between cases
and controls (Pillars et al., 2011).
Explanation
For cohort studies, authors should report whether they
conducted analyses to determine whether loss to follow-
up was differentially associated with other factors.
Another consideration is the approach for handling2http://cdn.elsevier.com/promis_misc/AMEPRE_gfa_mar2015.pdf
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failure to observe the outcome, which can vary greatly
depending upon the disease frequency measure such as
rates or risk (Box 6: Measures of Association and mea-
sures of impact). In cohort studies that use rates such as
animal-time at risk), the observed time of animals lost
to follow-up are included in the analysis, and the out-
come is censored. Because the approach used to analyse
censored data also varies, it should be described accord-
ingly (see item 7). When performing a survival analysis,
an unobserved outcome can be the result of loss to fol-
low-up or completion of the study. The authors should
clearly state whether the analysis treats these two forms
of censoring differently. When incidence risk (cumulative
Box 7
Missing data: problems and possible solutions
Missing data are common in observational research. In
studies conducted in populations with multiple organiza-
tional levels, missing data might occur and need to be
described at multiple levels. Rubin developed a typology of
missing data problems, based on a model for the probability
of an observation being missing (Rubin, 1976; Little and
Rubin, 2002). Data are described as missing completely at
random (MCAR) if the probability that a particular
observation is missing does not depend on the value of any
observable variable(s). Data are missing at random (MAR)
if, given the observed data, the probability that observations
are missing is independent of the actual values of the missing
data. For example, suppose younger dairy heifers are more
prone to missing pregnancy checks, but the probability of
missing the check is unrelated to the true pregnancy risk
after accounting for age. Then the missing pregnancy mea-
surements would be MAR in models including age. Data are
missing not at random (MNAR) if the probability of missing
still depends on the missing value even after taking the
available data into account. When data are MNAR, valid
inferences require explicit assumptions about the
mechanisms that led to missing data. In studies with multi-
ple organizational levels, data might be missing at the indi-
vidual level, group level or both. For example, the
probability of loss to follow-upmight depend on both group
and individual characteristics (Diaz-Ordaz et al., 2014).
Methods to deal with data missing at random (MAR) fall
into three broad classes: (Rubin, 1976; Little and Rubin,
2002) likelihood-based approaches (Lipsitz et al., 1999),
weighted estimations (Rotnitzky and Robins, 1997) and
multiple imputation (Schafer, 1997; Donders et al., 2006;
Rubin, 2008). Options for dealing with missing data in vet-
erinary literature have recently been published, along with
an assessment to determine the magnitude of bias that
might arise from a complete-case analysis (Dohoo, 2015).
Box 6
Measures of association and measures of impact
The terms used to describe metrics in epidemiology are,
unfortunately, not consistent. Therefore, care is needed
when deciding which concept is being described and if it
is appropriate for a particular situation. For example,
Dohoo et al. (2009) and the Centers for Disease Control
Principles of Epidemiology in Public Health Practice
(Anonymous, 2012) use the term Measures of Association
to describe measures such as odds ratio, rate ratio, while
the on-line text book Active Epi (http://ac-
tivepi.herokuapp.com/courses/active-epi-course) uses the
term Measure of Effect to describe these measures.
Regardless, of the broad grouping name used, these mea-
sures are usually the ratio of two measures of disease fre-
quency. The relative measures emphasize the strength of
an association, and are most useful in aetiological
research.
In addition, another set of measures are those are
designed to answer the question ‘How much of the dis-
ease burden in a population could be prevented by elimi-
nating the exposure?’ The category used to describe these
measures again differs by author. Dohoo et al. (Dohoo
et al., 2009) uses the term ‘Measures of Effect’, the CDC
Manual for Epidemiology uses the term ‘Measures of
Public Health Impact’ and Kleinbaum (Kleinbaum, 2009)
uses the term ‘Measures of Potential Impact’. These cal-
culations cover several concepts (and no unifying termi-
nology) exist, and incorrect approaches to adjust for
other factors are sometimes used (Greenland, 1998; Uter
and Pfahlberg, 2001). For example, Kleinbaum suggests
that the terms risk difference (RD), attributable risk and
excess risk are synonyms (Kleinbaum, 2009). Similarly,
Klieinbaum suggests that aetiological fraction (EF) in the
population can also be called the population attributable
risk, the population attributable risk per cent, the popu-
lation attributable risk proportion and the population
attributable risk fraction. The EF is appropriate for
cohort studies that estimate risk such as cumulative inci-
dence. If the study measures incidence rate, these terms
change accordingly. Another measure is the aetiological
fraction among exposed (EFe), which is alternatively
called the attributable risk per cent among exposed, the
attributable risk fraction among the exposed and the
attributable risk proportion among the exposed. This
measure focuses on the potential impact of the exposure
on the number of exposed cases, rather than the total
number of cases of the disease. Regardless of the number
used, authors should be aware of the strong assumptions
made in this context of using aetiological fractions
(Rockhill et al., 1998).
© 2016 The Authors. Zoonoses and Public Health published by Blackwell Verlag GmbH 19
A. M. O’Connor et al. STROBE-Vet Explanation and Elaboration
incidence) is the disease frequency measure, authors
should explain how they interpreted data about animals
that leave the study before the end of the study
In individually matched case–control studies, a crude
analysis of the odds ratio ignoring the matching usually
leads to an estimation that is biased towards unity (see
Box 2: Matching in case–control studies).
When authors use complex, multiple-stage sampling
schemes to select the study population, authors should
describe how this scheme is incorporated into the data
analysis, thereby providing a valid estimate of effect size
and precision.
When authors conduct multiple hypothesis tests, then
authors should indicate if they did or did not use a method
to adjust the definition of a ‘statistically significant’ P-value.
The description of the method should clarify whether an
adjustment approach for multiple comparisons was
employed within a specific hypothesis test.
12 (e). Describe any analyses used to assess the robustness
of the analyses (e.g. sensitivity analyses or quantitative
bias assessment)
Example
The national database used to sample controls did not
enable us to take into account the size of the flocks. There-
fore, counties with a large percentage of small flocks (<20
ewes) might have been overrepresented. To assess the influ-
ence of geographic selection bias, we conducted a sensitivity
analysis by using 2 methods: 1) weighting of controls in the
final model with weights being defined for each county as
the ratio of the percentage of flocks >20 ewes in the county
divided by the percentage of flocks >20 ewes at the national
scale, and 2) introduction of sheep production areas as ran-
dom coefficients in the final model (Fediaevsky et al.,
2009).
Explanation
Sensitivity analyses are useful to investigate whether or not
the main results are consistent with those obtained with
alternative analysis strategies or assumptions (Rothman
and Greenland, 1998). Issues that might be examined
include the criteria for inclusion in analyses, the definitions
of exposures or outcomes (Custer et al., 2006), which con-
founding variables merit adjustment, the handling of miss-
ing data (Wakefield et al., 2000; Dunn et al., 2001),
possible selection bias or bias from inaccurate or inconsis-
tent measurement of exposure, disease and other variables,
and specific analysis choices, such as the treatment of quan-
titative variables (see item 11). Sophisticated methods are
used increasingly to simultaneously model the influence of
several biases or assumptions (Greenland, 2003; Lash and
Fink, 2003; Phillips, 2003).
Results
The results section should give a factual account of what
was found, from the recruitment of owners/managers and
their animals and the description of the study populations to the
main results and ancillary analyses. The results should be
reported in sufficient detail for secondary use of the data (e.g.
for meta-analysis or risk assessment). The results section should
be free of interpretations and discursive or overly discussive text
reflecting the authors’ views and opinions.
13. Participants
13 (a). Report the numbers of owners / managers and
animals at each stage of study and at each relevant level of
organization –for example, numbers eligible, included in
the study, completing follow-up and analysed
Example 1
During the study period, a total of 2457 cats attended the
Small Animal Teaching Hospital. Of these, 237 records
were identified after the database search, and 174 cases met
the eligibility criteria (Trehy et al., 2014).
Example 2
Table 1 Structure of the data from 3027 lactation
records from dairy cows on Reunion Island (1993–1996)
Level Number
Average number per unit at
next-higher level Range
Region (highest level) 5 – –
Herd 50 10 3–16
Cow 1570 31.4 8–105
Lactation 3027 1.9 1–5
(Dohoo et al., 2001)
Explanation
Detailed information on the process of recruiting study
participants is important for several reasons. Those
included in a study often differ in relevant ways from the
target population to which results are applied. This might
result in estimates of prevalence or incidence that do not
reflect the experience of the target population and lead to
selection bias (see Box 1: Bias in observational studies).
Investigators should give an account of the numbers of
owners/managers and animals considered at each stage of
recruiting study participants and at each level of organization.
The choice of a target population and the detailed criteria for
inclusion of participants’ data in the analysis should be described.
Depending on the type of study, this might include the number
of owners/managers and animals found to be eligible, the num-
ber included in the study, the number examined, the number fol-
lowed up and the number included in the analysis. Information
on different organizational levels might be required, if sampling
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of study participants is carried out at two or more organizational
levels (multistage sampling). In case–control studies, we advise
that authors describe the flow of participants separately for case
and control groups. (Schulz and Grimes, 2002) Controls can
sometimes be selected from several sources, including veterinary
clinics and community dwellers.
13 (b). Give reasons for non-participation at each stage
and at each relevant level of organization
Example 1
We investigated a total of 233 known OJD infected flocks to
identify eligible flocks, of which the eligibility of 32 (13.7%)
could not be determined because the farmer refused to partic-
ipate for various reasons (lack of interest (6), old age or health
problems (4), inability to muster sheep (2), anger about past
surveys (1) and no reason given (19)) (Dhand et al., 2007).
Example 2
Reasons for exclusion were lack of a result for serum
cobalamin (35 cats), cobalamin measured using a different
method (13 cats), or incomplete clinical records (15 cats). A
record of prior cobalamin supplementation (within the three
months before presentation) was identified in 18 cases (16 with
serum cobalamin greater than the reference interval, 1 with
cobalamin within the reference interval and 1 with cobalamin
below the reference interval) (Trehy et al., 2014).
Explanation
Although low participation does not necessarily compro-
mise the validity of a study, transparent information on
participation and reasons for non-participation are essen-
tial. Also, as there are no universally agreed definitions for
participation, response or follow-up rates, readers need to
understand how authors calculated such proportions (Slat-
tery et al., 1995; Galea and Tracy, 2007). Explaining the
reasons why owners/managers or animals no longer partici-
pated in a study or why they were excluded from statistical
analyses helps readers judge whether the study population
was representative of the target population and whether
bias was possibly introduced. For example, in a survey of
horse owners investigating an equine health outcome, non-
participation due to reasons unrelated to a horses’ health sta-
tus (such as the survey not being delivered due to an incorrect
address) might affect the estimate precision but is not likely to
introduce bias. Conversely, if owners/managers opt out of the
survey because their horse is ill or perceived to be in excellent
health, the results might underestimate or overestimate the
population’s prevalence of ill health. If failure to participate or
loss to follow-up during the study is related to both an expo-
sure of interest and the outcome, the relationship between the
exposure and the outcome might also be biased.
13 (c). Consider use of a flow diagram and/or a diagram of
the organizational structure
Example
Figure extracted from publication(Menzies et al., 2012)
Explanation
An informative and well-structured flow diagram can read-
ily and transparently convey information that might other-
wise require a lengthy description (Egger et al., 2001). The
diagram might usefully include the main results such as the
number of events for the primary outcome. The flow chart
might need to include information for both owners/man-
agers and animals as well as information at multiple organi-
zational levels, if applicable.
14. Descriptive data on exposures and potential
confounders
14 (a). Give characteristics of study participants (e.g.
Demographic, clinical, social) and information on
exposures and potential confounders by group and level of
organization, if applicable
Example
Table 2 Descriptive statistics for variables of interest in calves born in Fall 2005-2008
Year Pinkeye: n ADG: kg/d (SD) URFAT: cm (SD) UFAT: cm (SD) UREA: cm2 (SD) UPFAT: % (SD) LIVEWT: kg (SD)
2005 Case: 15 0.92 (0.37) 0.58 (0.38) 0.53 (0.36) 55.13 (17.55) 4.45 (1.02) 344.40 (98.91)
Neg: 92 1.01 (0.40) 0.66 (0.34) 0.62 (0.38) 60.21 (16.48) 4.72 (1.12) 382.59 (100.75)
2007 Case: 9 0.98 (0.55) 0.60 (0.42) 0.54 (0.43) 59.90 (22.45) 4.27 (0.99) 380.16 (140.17)
Neg: 123 0.98 (0.49) 0.65 (0.39) 0.59 (0.35) 60.69 (18.23) 4.55 (0.98) 381.99 (116.58)
2008 Case: 3 0.76 (0.39) 0.70 (0.45) 0.62 (0.34) 53.10 (18.26) 4.55 (0.32) 353.95 (120.51)
Neg: 126 1.02 (0.37) 0.71 (0.29) 0.65 (0.31) 65.77 (17.80) 4.76 (1.15) 406.73 (96.51)
Total Case: 27 0.92 (0.42) 0.59 (0.39) 0.55 (0.37) 56.50 (18.79) 4.41 (0.94) 357.38 (112.73)
Neg: 341 1.00 (0.42) 0.67 (0.34) 0.62 (0.34) 62.44 (17.75) 4.63 (1.09) 391.29 (105.63)
(Funk et al., 2014)
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Example 2
Explanation
Readers need descriptions of study participants and their
exposures to judge the generalizability of the findings or
use the data in secondary analyses. In veterinary studies,
this might include descriptive information about the own-
ers/managers, herds, pens and animals. In studies that com-
pare groups, the descriptive characteristics and numbers
should be given by group. The ‘group’ variable would be
exposure level or outcome status, depending on the study
subject selection method. Inferential measures such as stan-
dard errors and confidence intervals should not be used to
describe the variability of characteristics, and significance
tests and P-values should be avoided when describing the
baseline characteristics of the study population. In cohort
studies, it might be useful to document how an exposure
relates to other characteristics and potential confounders.
Authors could present this information in a table with col-
umns for participants in two or more exposure categories,
which permits the reader to judge the differences in con-
founders between these categories.
Information about potential confounders, including
whether and how they were measured, influences judgments
about study validity. We advise authors to summarize con-
tinuous variables for each study group by giving the mean
and standard deviation, or, when the data have an asymmet-
rical distribution (as is often the case), the median and per-
centile range (e.g. 25th and 75th percentiles). Variables
made up by small number of ordered categories (such as
stages of disease I to IV) should not be presented as continu-
ous variables; it is preferable to give numbers and propor-
tions for each category. The SAMPL guidelines provide
recommendations for reporting descriptive statistics for dif-
ferent variable types (Lang and Altman, 2013). We recom-
mended that descriptive information be provided for all
variables measured in the study, regardless of whether they
are included in the final analyses. To allow the reader to
evaluate the statistical power for an individual variable and
the probability of a type I error given the total number of
variables evaluated, authors should provide information on
the number of variables and the distribution of data among
each variable’s categories. Some journals might be reluctant
to publish extensive descriptive tables due to word limits or
page constraints. In these cases, we recommend that the
descriptive information be provided as supplementary mate-
rial and the total number of associations tested be provided
in the main text. The approach for presenting inferential
statistics is discussed in item 15. The decision to combine
descriptive statistics (item 13) and inferential statistics (item
15), into one table, as was done in the example provided for
this item, depends on author and journal preference.
14 (b). Indicate number of participants with missing data
for each variable of interest and at all relevant levels of
organization
Example
In total 112 farmers returned useable prospective records
on 2143 litters. . . . Cause and timing of piglet death data
were returned for 2826 piglets from 1304 litters from
111 farms. . . . With the exception of unknown sow par-
ity, incomplete piglet mortality records were excluded
from the risk factor analysis, this amounted to 1714 pig-
let records. Data on a cohort of 25,761 piglets from 2143
litters from 112 farms were analysed (KilBride et al.,
2012).
Explanation
As missing data might bias or affect generalizability of
results, authors should tell readers the amounts of missing
data for exposures, potential confounders and other impor-
tant characteristics of study subjects (see item 12c and
Box 7: Missing data: problems and possible solutions).
Table 1 Descriptive statistics (mean, (SD, median, min, max)) for PA-MNT (Pressure Algometry- Mechanical Nociceptive
Threshold in kg/f) for calves scarified on d 0 (n=number of eyes)
d (n) Landmark 1 Landmark 2 Landmark 3 Landmark 4 (Control)
Scarified eyes
4 (19)
5.2 (1.9, 4.8, 1.4, 10.1) 2.0 (1.2, 1.8, 0.2, 6.5) 4.0 (2.4, 3.7, 0.5, 10.3) 5.5 (2.2, 5.2, 1.1, 11.1)
1 (19) 3.9 (1.9, 3.7, 0.7, 10.0) 1.7 (1.1, 1.4, 0.1, 5.1) 3.1 (2.1, 2.5, 0.1, 8.3) 3.9 (1.7, 3.9, 0.7, 11.2)
3 (16) 3.1 (1.2, 3.0, 0.9, 6.9) 1.3 (0.8, 1.2, 0.2, 3.3) 2.6 (2.5, 1.6, 0.2, 11.2) 3.2 (1.1, 3.2, 0.4, 6.6)
balance of table omitted. . .
(Dewell et al., 2014)
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Authors should clearly describe the number of animals
missing due to elective euthanasia or culling. Authors also
should report numbers at each level or organization. A
study with a small number of missing observations from
each herd might have different implications than a study
where all of the missing data are from one herd. We advise
authors to use their tables and figures to enumerate
amounts of missing data.
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14 (c). Summarise follow-up time (e.g. Average and
total amount), if appropriate to the study design
Example
A total of 548 calves were recruited and followed up to
51 weeks or until they died, contributing a total of 25,104
calf weeks (481.1 calf years) of life to the study. Five ani-
mals were lost to follow up due to non-compliance to study
protocol or were stolen from the study farms. A total of 88
calves died before reaching 51 weeks of age, giving a crude
mortality rate of 16.1 (13.0–19.2; 95% CI) per 100 calves in
their first year of life. Of the 88 animals that died, 33 deaths
were attributed to East Coast fever, 10 to haemonchosis,
and 6 to heartwater (Thumbi et al., 2014).
Explanation
Readers need to know the duration and extent of follow-up
for the available outcome data. Authors can present a sum-
mary measure of the follow-up such as the mean follow-up
time, median follow-up time or both, as appropriate. The
mean allows a reader to estimate the total number of ani-
mal-years by multiplying it with the number of study sub-
jects. Authors also might present minimum and maximum
times or percentiles of the distribution to show readers the
spread of follow-up times. They might report total animal-
years of follow-up or some indication of the proportion of
potential data that were captured (Clark et al., 2002). All
such information might be presented separately for animals
in two or more exposure categories.
15. Outcomes
Example 1
In the reduced dataset of 200 cats, 126 (63%) cats were classed
as overweight and 74 (37%) as normal weight. The BCS distri-
bution for the study population without the cats that were
excluded on medical grounds (n = 206) as shown in . . ..
Table 3 Variables assessed as potential risk factors for being
obese or overweight (O/wgt) grouped according to model of
200 cats included in the study (New Zealand 2007).
Model Variable
Category
levels
Cats
(n)
O/wgt
(%) p-value
Cat characteristics Age (years)a ≤2 29 41 0.002
3–7 87 60
8–12 58 69
≥13 24 88
Desexed?a Entire 9 11 0.002
Desexed 190 65
Gender Male 109 66 0.463
Female 92 60
. . . balance of table omitted
(Cave et al., 2012)
Example 2
Table 4 Multivariable model of risk factors for the occur-
rence of Campylobacter at first-depopulation in 354 con-
ventional broiler flocks in Northern Ireland, June 2001 to
May 2002
Variable
No. of
flocks
Positive
(%)
Odds
ratio 95% CI
p-Value
(Wald’s)
p-Value
of factor
Age at samplinga
Per day
increase
354 42.9 1.16 1.05–1.28 0.005 0.004
Number of houses on site
One 125 31.2 1 – – 0.018
Two 88 39.8 1.39 0.60–3.21 0.447 –
Three or
more
141 55.3 2.86 1.32–6.22 0.008 –
. . . balance of table omitted
(McDowell et al., 2008)
Example 3
The FEC results were reported as ep5 g [eggs per 5 grams
of feces]. The range of egg counts was from 0 to 419 ep5 g.
Table III summarizes the range, mean, and median counts
for the 4 regions.
Table III Summary statistics for 1947 fecal egg counts of
Trichostrongle-type eggs per 5 g of feces (ep5 g) from sam-
ples collected from 38 Canadian dairy herds.
Range Mean Median SD Variance N
PEI 0–419 12.8 2 37.8 1428.5 1016
Quebec 0–241 7.8 1 23.6 558.7 610
Ontario 0–48 2.2 0 6.1 37.2 163
Saskatchewan 0–189 5.6 0 25.5 652.7 157
Overall 0–419 9.8 1 29.0 998.7 1946
SD – standard deviation
(Nødtvedt et al., 2002)
Explanation
Before addressing the possible association between
exposures (risk factors) and outcomes, authors should
report relevant descriptive data. It might be possible and
meaningful to present unconditional measures of associa-
tion in the same table that presents the descriptive data.
15 (a). Report outcomes as appropriate for the study
design and summarize at all relevant levels of
organization
Item 15 differs from item 14, in that 15 explicitly relates to
the outcome (event) information. In cross-sectional and
risk-based cohort studies, authors should report the num-
ber of events for each outcome of interest. For example, in
Example 1, this information is provided in the table. Con-
sider presenting this information separately for participants
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in different categories of key exposures of interest. Example
1 also includes information relevant to item 14 such as infor-
mation about the distribution of potential confounders. For
rate-based cohort (longitudinal) studies, consider reporting
the event rate per animal-year of follow-up. For case–control
studies, the focus will be on reporting exposures separately for
cases and controls as frequencies or quantitative summaries.
Describing the outcome at all organizational levels
requires balancing between complete reporting and ‘infor-
mation overload’. If the outcome analyses are all carried out
at the lowest level, the outcome at all higher levels might not be
need to be reported. However, the authors should provide the
reader with some idea as to how the outcome varies across higher
level units. In Example 3, the hierarchy consisted of province
(n = 4), herd (n = 38), cow (n = 304) and sample (n = 1946).
The authors provided some evidence of the variability in faecal
egg count across provinces by providing descriptive statistics in a
tabular form by province. In some cases, it might be appropriate
to report the outcome at different timepoints (e.g. for a longitudi-
nal study).
In Example 4, the organizational levels were herd
(n = 210) and cows (n  5000). To indicate the range of
incidence rates of several diseases across herds, they presented
those rates as box-and-whisker plots, which effectively convey
the cross-herd variability. When figures are used for presenta-
tional clarity, tables of numerical values, which are required for
meta-analyses and risk analyses, should be included in the
main text or supplemental material.
Multilevel studies are often analysed using random-
effects models. In these cases, the authors should present the
variance estimates at all levels to provide information about
the outcome variability across all organizational levels.
15 (b). For proportions and rates, report the numerator
and denominator
It is important to present both numerator and denomi-
nator values, so users can calculate unconditional risk
ratios (RR) or odds ratios (OR). In Example 1 (cross-
sectional study), the number of animals in the exposure
variable categories and the per cent with the outcome
are reported. These values allow the reader to compute
the numerator and denominator values for a RR. In
Example 2 (case–control study), the actual numerator
and denominator values (listed by key exposure variable
categories) and the associated ORs are presented. For
rate-based studies, the number of outcome events and
amount of animal-time at risk should be presented for
key predictor categories.
15 (c). For continuous outcomes, report the number of
observations and a measure of variability
For quantitative outcomes, present appropriate summary
measures. For (approximately) normally distributed values,
the authors should report the mean and standard deviation
(SD) or variance. We do not recommend reporting the
standard error of the mean, because standard error is an infer-
ential statistic rather than a descriptive one. For non-normally
distributed outcomes, report either the mean and SD of a nor-
mally distributed transformed outcome or consider reporting
the median and interquartile range (or complete range) of the
original variable. In Example 3, the mean and SD as well as
the median and range have been presented.
16. Main results
16 (a). Give unadjusted estimates and, if applicable,
adjusted estimates and their precision (e.g. 95%
confidence interval). Make clear which
confounders and interactions were adjusted. Report
all relevant parameters that were part of the
model
Example 1
(Willeberg et al., 2012)
Table 2 Example 1: model estimates of the effects of alternative confounder adjustments based on data from Table 1
# of cattle purchased
from positive herds in
the previous quarter
Full
model ORf
estimatesa
Simplified model ORf estimates
Crude ORf1
b 2c 3d
>20 7.4 8.1 9.7 9.9 9.7
10-20 11.0 11.9 14.2 13.8 14.2
1-10 3.8 3.8 5.0 4.8 5.0
. . . balance of table omitted
For details on the multivariable model, see (Nielsen et al., 2007)
aBased on the full model with four significant risk factors as presented by Nielsen et al. (2007).
bModel 1: as the full model without the risk factor: ‘herd size’.
cModel 2: as Model 1 without the risk factor: ‘region of the country’.
dModel 3: as Model 2 without the risk factor: ‘number of Salmonella-positive herds in the previous quarter within a 2 km radius’, i.e., model with the
primary risk factor, controlling for repeated measurements within herds.
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Example 2
(Pires et al., 2013)
Explanation
In many situations, authors might present the results of
unadjusted or minimally adjusted analyses and those from
fully adjusted analyses. We advise giving the unadjusted
analyses together with the main data, for example the num-
ber of cases and controls that were exposed or not. This
allows the reader to understand the data behind the mea-
sures of association (see also item 15). For adjusted analy-
ses, report the number of animals in the analysis, as this
number might differ because of missing values in covariates
(see also item 12c). Estimates should be given with confi-
dence intervals.
Readers can compare unadjusted measures of associa-
tion with those adjusted for potential confounders and
judge by how much, and in what direction, they chan-
ged. Readers might think that ‘adjusted’ results equal
the causal part of the measure of association, but
adjusted results are not necessarily free of random sam-
pling error, selection bias, information bias or residual
confounding. Thus, great care should be exercised when
interpreting adjusted results, as the validity of results often
depends crucially on complete knowledge of important
confounders, their precise measurement and appropriate
specification in the statistical model (see also item 20)
(Smith and Phillips, 1990; Christenfeld et al., 2004).
Data non-independence is frequently encountered in
animal studies and often addressed by fitting a
random-effects model. It is important that these ran-
dom effects be reported (and interpreted), because they
are as important a model component as the fixed
effects (see Example 2).
16 (b). Present category boundaries when continuous
variables were categorized
Explanation
Categorizing continuous data has several important
implications for analysis (Box 3: Grouping / C) and also
affects the presentation of results. In tables, outcomes
should be given for each exposure category, for example
as counts of animals at risk, animal-time at risk, if rele-
vant separately for each group (e.g. cases and controls).
Details of the categories used might aid comparison of
studies and meta-analysis. If data were grouped using con-
ventional cut points (e.g. below normal, normal reference
range, above normal for body temperature), group bound-
aries such as range of values can be derived easily, except
for the highest and lowest categories. If quantile-derived cat-
egories are used, the category boundaries cannot be inferred
from the data. At a minimum, authors should report the
category boundaries; it is helpful also to report the range of
the data and the mean or median values within categories.
Commonly, category boundaries are presented directly in
the table with model results (see Example 1).
Table 3 Final multivariable random effects logistic regression models of associations between barn thermal environment
parameters, pig-, pen- and cohort-level risk factors and Salmonella shedding in finishing pigs in three sites. Multilevel
multivariable logistic models with random intercepts at pig-, pen- and cohort-levels.
Models
Measured
at level
Independent
variable Beta SE OR 95% CI p-Value
Model 1 Intercept 2.65 0.58 – – –
Pig Agef 1.18 0.017 0.7 0.65–0.74 <0.001
Pen Cold exposure 12hi 0.44 0.2 1.51 1.02–2.25 0.03
Cohort Nursery statusg 2.16 0.52 4.14 2.79–17.15 <0.001
Farm Site
A vs B 0.93 0.61 2.52 0.76–8.42
A vs C 0.38 0.63 1.46 0.42–5.04
B vs C 1.3 0.64 3.69 1.06–12.86
. . . balance of table and footnotes omitted
Cohort (Varh = 0.77 (0.43), % = 11.48); Pen (Varh = 1.69 (0.34), % = 25.19); Pig (Varh = 0.96 (0.21), % = 14.31); Total (Varh = 6.71)
Cohorts (n = 18); Pens (n = 361); Pigs (n = 899); Individual fecal samples (n = 6751); Salmonella prevalence (6.58%)
h(Variance components, standard error and proportion of variance at the cohort-, pen- and pig-level. Individual fecal sample variance: p 2/3 = 3.29
(latent-variable technique).
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16 (c). If relevant, consider translating estimates of relative
risk into absolute risk for a meaningful time period
Example
Table 4 Population attributable fraction (PAF) and 95%
confidence interval for selected explanatory variables
regarding 295 dog owners in Taiwan (2004)
PAF (%)
95% CI
Lower limit Upper limit
History of unsuccessful ownership 33 11 50
Spayed after giving birth a 22 3 37
Soiling 17 6 26
Barking 13 1 23
Barking and soiling combined 23 3 40
Neighbor complaints b 11 1 20
aDo you think that a female dog would be healthier if she had one litter
before being fixed?
bHave there been any neighborhood problems or complaints concern-
ing your dog?
(Weng et al., 2006)
Explanation
In many circumstances, the absolute risk associated with
an exposure is of greater interest than the relative risk.
Absolute measures such as risk different and measures
of impact such as aetiological fraction in the exposed or
aetiological fraction in the population might be useful to
gauge how much disease can be prevented if the expo-
sure is eliminated (example above). For this reason, such
measures are of interest to the end-users. These mea-
sures should preferably be presented together with a
measure of statistical uncertainty, although CI calcula-
tions might be difficult for estimates derived from mul-
tivariable models. Authors should be aware of the strong
assumptions made in this context, including a causal
relationship between a risk factor and disease (also see
Box 6: Measures of Association and measures of impact)
(Rockhill et al., 1998). Because of the semantic ambigu-
ity and complexities involved, authors should report the
method used to calculate such measures, ideally giving
Box 3
Grouping / Categorization
There are several reasons why continuous data might be grouped (Altman, 2005). When collecting data, it might be better
to use an ordinal variable than to seek an artificially precise continuous measure for an exposure based on recall over sev-
eral years. Categories might also be helpful for presentation, for example to present all variables in a similar style, or to
show a dose–response relationship.
Grouping might also be done to simplify the analysis, for example to avoid an assumption of linearity or when investigating
interactions between two continuous variables. However, grouping loses information and might reduce statistical power
(Cohen, 1983) especially when dichotomization is used (Zhao and Kolonel, 1992; MacCallum et al., 2002; Royston et al.,
2006). If a continuous confounder is grouped, residual confounding might occur, whereby some of the variable’s confound-
ing effect remains unadjusted (see Box 5: Confounding) (Cochran, 1968; Becher, 1992). Increasing the number of categories
can diminish power loss and residual confounding, and is especially appropriate in large studies. Small studies might use
few groups because of limited numbers.
Investigators might choose cut points for groupings based on commonly used values that are relevant for diagnosis or prog-
nosis, for practicality, or on statistical grounds. They might choose equal numbers of individuals in each group using quan-
tiles (Clayton et al., 1993). On the other hand, one might gain more insight into the association with the outcome by
choosing more extreme outer groups and having the middle group(s) larger than the outer groups (Cox, 1957). In case–
control studies, deriving a distribution from the control group is preferred as it is intended to reflect the source population.
Readers should be informed if cut points were selected post hoc. In particular, if the cut points were chosen to minimize a
P value, the true strength of an association will be exaggerated (Altman et al., 1994).
When analysing grouped variables, it is important to recognize their underlying continuous nature. For instance, a possible
trend in risk across ordered groups can be investigated. A common approach is to model the rank of the groups as a contin-
uous variable. Such linearity across group scores will approximate an actual linear relation if groups are equally spaced but
not otherwise. Il’ysova et al. (Il’yasova et al., 2005) recommends publication of both the categorical and the continuous esti-
mates of effect, with their standard errors, to facilitate meta-analysis, as well as providing intrinsically valuable information
on dose–response. One analysis might inform the other and neither is assumption-free. Authors often ignore the ordering
and consider the estimates (and P-values) separately for each category compared with the reference category. This might be
useful for description, but might fail to detect a real trend in risk across groups. Recent method developments, such as frac-
tional polynomials that fit a wide range of nonlinear relationships (Royston and Sauerbrei, 2008), and the availability of soft-
ware to implement these methods in standard software packages reduces the need to routinely categorize variables.
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the formulae used or a citation for the formula (Uter
and Pfahlberg, 2001).
17. Other analyses: report other analyses done, such as
sensitivity / robustness analysis and analysis of subgroups
Examples
Sensitivity testing was done for each model by lowering
prior test accuracy estimates’ mode by 10 percentage points
(e.g., ELISASe from 0.95 to 0.85), relaxing the beta distribu-
tion to a 50th percentile and reducing the lower bound 10
percentage points below the previous lower bound (e.g.,
ELISASe from 0.9 to 0.8) and using a uniform beta distribu-
tion as the prior distribution for exposure prevalence
(Haley et al., 2011).
Explanation
When an observational study has a single primary question,
the reader reasonably might assume that all the study
design features were selected with that question in mind
(e.g. sample size and power, the interpretation of the alpha
error, accuracy enhancement and bias reduction measures
and potential confounders). If additional questions and
analyses were included in the study, the authors must tell
the readers. Lack of full disclosure distorts the interpreta-
tion of everything from bias control effectiveness to multi-
plicity considerations. The reader must be informed of all
secondary analyses (e.g. conducting sensitivity analyses, or
testing for interactions or particular subgroup analyses)
were pre-specified (a priori, e.g.) or were steered by the data
themselves (post hoc analyses). For example, ‘non-signifi-
cant’ interactions or risk factors are ‘results’ unto them-
selves, and they assist in framing the context of ‘significant’
results. Post hoc subgroup analyses that appear more ‘excit-
ing’ than the answers to the primary question must be
viewed cautiously.
Researchers often must extrapolate the ‘base’ values of
relevant input data. Examples include declaring prior dis-
tributions for Bayesian analyses and declaring the diagnos-
tic test accuracy used for adjusting apparent prevalences to
true prevalences. In some instances, distributions are
unknown or variables have great inherent contextual varia-
tion, which leads to considerable uncertainty. When faced
with such assumptions about uncertainty, authors should
conduct ‘sensitivity analyses’ to discover the sensitivity (ro-
bustness) of the conclusions with respect to reasonable
variation from base values. Additionally, the data often lead
to decisions about diagnoses or other categorizations; how-
ever, alternative decision criteria might be available. In
these situations, it is also appropriate to examine and
report the sensitivity of the conclusions with respect to the
decision criteria used.
Discussion
The discussion section provides readers with the authors’
interpretation of the results once they have been placed in
context such as the approach to the study and prior rele-
vant findings. Authors should also emphasize the study
design aspects that enhance the internal and external valid-
ity of the findings to aid the readers’ understanding of the
data and the conclusion’s strength. In addition, the authors
should outline the limitations of the design and their
impact on the findings.
18. Summarize key results with reference to study
objectives
Examples
. . .a large field data collection from 14 endemically infected
dairy herds was used to investigate the hypothesis that cat-
tle with persistently high antibody levels are at high risk of
shedding S. Dublin and therefore are candidates to be
culled or at least managed so that they do not spread the
Box 8
Interaction (effect modification): the analysis of joint
effects
Interaction exists when the association of an exposure with
the risk of disease differs in the presence of another expo-
sure. One problem in evaluating and reporting interactions
is that the effect of an exposure can be measured in two
ways: as a risk ratio (or rate ratio) or as a risk difference
(or rate difference). The use of the ratio leads to a multi-
plicative model, while the use of the difference corresponds
to an additive model (Rothman et al., 1980; Saracci, 1980).
A distinction is sometimes made between ‘statistical inter-
action’ which can be a departure from either a multiplica-
tive or additive model, and ‘biologic interaction’ which is
measured by departure from an additive model (Rothman,
2012). However, neither additive nor multiplicative models
point to a particular biologic mechanism. Regardless of the
model choice, the main objective is to understand how the
joint effect of two exposures differs from their separate
effects (in the absence of the other exposure). The Human
Genomic Epidemiology Network (HuGENet) proposed a
layout for transparent presentation of separate and joint
effects that permits evaluation of different types of interac-
tion (Botto and Khoury, 2001). A difficulty is that some
study designs, such as case–control studies, and several sta-
tistical models, such as logistic or Cox regression models,
estimate risk or rate ratios and intrinsically lead to multi-
plicative modelling.
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infection to herd mates. Despite that fact that there were
seropositive animals in many of the age groups at most of
the herd visits, indicative of the herds being endemically
infected, the general probability of shedding was very low
. . . for S. Dublin. . . . Based on this study material there was
no evidence that animals with persistently high antibodies
over a period of at least 6 months were at higher risk of
shedding S. Dublin bacteria in their faeces than other
seropositive cattle (Nielsen, 2013).
Explanation
It is good practice to begin the discussion with a short sum-
mary of the main findings of the study. The short summary
reminds readers of the main findings and might help them
assess whether the subsequent interpretation and implica-
tions offered by the authors are supported by the findings.
19. Discuss strengths and limitations of the study, taking
into account sources of potential bias or imprecision.
Discuss both direction and magnitude of any potential
bias
Example
Because of the steps involved in making a diagnosis of lep-
tospirosis . . . it is unlikely that a dog examined at a veteri-
nary teaching hospital would be falsely diagnosed as having
leptospirosis when it did not. It is more likely that lep-
tospirosis was not diagnosed in some dogs with the disease.
This of bias is unlikely to be substantial, because the num-
ber of dogs with undiagnosed leptospirosis is probably a
very small proportion of all dogs examined at veterinary
teaching hospitals. For example, if leptospirosis had been
underdiagnosed by a factor of 10-fold, < 0.04% of the
1,819,792 dogs examined at veterinary teaching hospitals
between 1970 and 1998 would have been classified as cases
rather than controls. For the age category 4 to 6.9 years,
this bias would result in a change in the estimated OR from
1.7259 to 1.7295 (a change of 0.21%), assuming equal pro-
portions of misdiagnoses in the 4 to 6.9 years and < 1 year
age categories. We do not expect the proportion of dogs
with leptospirosis in which the disease is not diagnosed at
veterinary teaching hospitals to be greater than 10-fold that
recorded in the VMDB, so bias from misclassification of
leptospirosis status was unlikely to be substantial in this
study (Ward et al., 2002).
Explanation
Authors should highlight specific strengths of their study
relative to other work in the field (e.g. a study based on true
random sampling versus convenience sampling). However,
the identification and discussion of the limitations of a
study are an essential part of scientific reporting. It is
important not only to identify the sources of bias and con-
founding that could have affected results, but also to dis-
cuss the relative importance of different biases, including
the likely direction and magnitude of any potential bias
(see Box 1: Bias in observational studies and Box 5: Con-
founding and item 9 about bias in method and materials).
Authors should also discuss the impact of imprecision
and uncertainty on the interpretation of results. Result
imprecision could result from a small sample size, which
produces a wide CI such as low effect size precision. Here,
we refer to uncertainty as missing knowledge related to
specific factors, parameters or model specification rather
than sample size (Firestone et al., 1997).
When discussing limitations, authors might compare the
study being presented with other studies in the literature in
terms of validity, generalizability and precision. In this
approach, each study can be viewed as a contribution to
the literature, not as a stand-alone basis for inference and
action (Poole et al., 2003).
20. Give a cautious overall interpretation of results
considering objectives, limitations, multiplicity of
analyses, results from similar studies and other relevant
evidence
Examples
We conclude that the presence of unresolved infection in a
herd is a contributor to further bTB episodes in the first
2 years after clearance. These findings agree with the inves-
tigations in the UK and Ireland, which have shown repeat-
edly that bTB spreads from de-restricted herds to clear
herds via the transfer of undetected infection after de-
restriction [] (Dawson et al., 2014).
Explanation
In accordance with the original STROBE document, we
encourage authors to provide the reader with a thoughtful
conclusion and a rationale based on the principles of causal
inference rather than using P-values less than 0.05 (or any
other arbitrary P-value cut-off) as an indicator of a causal
association. The heart of the discussion section is the inter-
pretation of a study’s results. When interpreting results,
authors should consider the place of the study on the dis-
covery-to-verification continuum and potential sources of
bias, including loss to follow-up and non-participation (see
also items 9, 12 and 19).
In the veterinary field, studies evaluating large numbers
of independent variables are common occurrences. The
probability that at least one significant finding will be a type
I error increases as the number of hypotheses tested within
a study increases. Therefore, in the limitations section,
authors should note the probability of type I errors as an
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alternative explanation for the associations observed when
appropriate.
The rationale should address the concepts used to estab-
lish causation. The conclusions presented should consider
the role chance and bias could play in the findings of the
current study (discussed in item 19) as well as those of pre-
vious studies on the same topic. Currently, many guides on
causal thinking exist, such as those proposed by Bradford
Hill and others (Kaufman and Poole, 2000; Rothman and
Greenland, 2005; Hill, 2015). While we are not proposing a
formulaic application of guidelines or criteria, readers
might find it helpful if the authors document the concepts
of causal inference to assist them in understanding the con-
clusion. For example, how strong is the association with
the exposure? Did exposure precede disease onset? Is the
association consistently observed in different studies and
settings? Is there supporting evidence from experimental
studies, including laboratory and animal studies? How
specific is the exposure’s putative effect, and is there a
dose–response relationship? Is the association biologically
plausible? A discussion of the existing external evidence,
from different types of studies, should always be included,
but might be particularly important for studies reporting
small increases in risk. Furthermore, authors should put
their results in context with similar studies and explain
how the new study affects the existing body of evidence,
ideally by referring to a systematic review.
21. Discuss the generalizability (external validity) of the
study results
Example
The findings from this study would be difficult to extrapo-
late to other countries, because of the differences in bTB
management policies between countries. However, this
study has added weight to the growing body of evidence to
show that residual infection in herds poses a problem to
bTB eradication schemes, and that the goal should be to
maximize within-herd sensitivity in the management of this
problematic infection (Dawson et al., 2014).
Explanation
Generalizability, also called external validity or applicabil-
ity, is the extent to which the results of a study can be
applied to other circumstances (Campbell, 1957). There is
no external validity per se; the term is meaningful only with
regard to clearly specified conditions (Justice et al., 1999).
Can results be applied to an individual, groups or popula-
tions that differ from those enrolled in the study with
regard to age, sex, breed or other characteristic, such as the
production system for livestock populations? Are the nat-
ure and level of exposures comparable, and the definitions
of outcomes relevant to another setting or population? Are
results from one country applicable to other countries?
The question of whether the results of a study have exter-
nal validity is often a matter of judgment that depends on
the study setting, the characteristics of the participants, the
exposures examined and the outcomes assessed. Thus, it is
crucial that authors provide readers with adequate infor-
mation about the setting and locations, eligibility criteria,
the exposures and how they were measured, the definition
of outcomes and the period of recruitment and follow-up.
The degree of non-participation and the proportion of
unexposed participants in whom the outcome develops are
also relevant. Knowledge of the absolute risk and preva-
lence of the exposure, which will often vary across popula-
tions, are helpful when applying results to other settings
and populations. Of course, the need for inclusion of these
features is discussed throughout this document and these
summary statements only serve as a reminder of the need
for complete reporting of research design and results in the
context of external validity (See Box 6: Measures of Associ-
ation and measures of impact.).
Other information
22. Transparency
22 (a). Give the source of funding and the role of the
funders for the present study and, if applicable, for the
original study on which the present article is based
Example
Funding: This study was funded by Pfizer Animal Health
(www.Zoetis.com). The grant number was 1329. The fol-
lowing Pfizer personnel were observers during the study:
Jeremy Salt, Michael Pearce, Tony Simon and Marie-Odile
Hendrickx. The funders had no role in study design, data
collection and analysis, decision to publish, or preparation
of the manuscript, except attendance at project coordina-
tion meetings as observers, and commenting on the draft
manuscript (Jones et al., 2013).
Explanation
Because of concerns about funding agencies’ influence on
study design and the potential for selective reporting,
funding sources and the role of funding agencies should
be described explicitly. In human health, several investi-
gations show strong associations between the source of
funding and the conclusions of research articles (David-
son, 1986; Stelfox et al., 1998; Bekelman et al., 2003; Lex-
chin et al., 2003). To our knowledge, there are no similar
associations detected in observational studies conducted
in veterinary science. However, the possibility for bias
could exist, and it is best practice to disclose all funding
sources.
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22 (b). Conflict of interests. Describe any conflict of
interests, or lack thereof, for each author
Dr. . . . has provided scientific consulting services to Zoetis
Inc. (manufacturer of the CCFA product). This does not
alter the authors’ adherence to all the journal policies on
sharing data and materials (Kanwar et al., 2014)
Explanation
In human health, there is evidence that authors or funders
might have conflict of interests that influence any of the
following: the design of the study (Safer, 2002), choice of
exposures (Aspinall and Goodman, 1995; Safer, 2002), out-
comes (Chan et al., 2004), statistical methods (Melander
et al., 2003) and selective publication of outcomes and
studies (Chan et al., 2004; Scherer et al., 2007). Potential
conflict of interests include financial arrangements outside
of research funding that could influence authors. Authors
should disclose any financial support, including grants,
scholarships and sponsorships received. Gifts that might
not be associated directly with the project, such as labora-
tory equipment, travel, consulting agreements and hono-
raria, but still establish a relationship with a company or
agency should also be disclosed. This information alerts
users the relationship and allows them to assess the poten-
tial for bias in conducting and reporting the study.
22 (c). Describe the authors’ roles – provision of an
authors’ declaration of transparency is recommended
Example
H.M.S., B.N., G.H.L. and P.B. conceived and designed the
study. N.K., H.M.S., B.N., G.H.L., J.V., P.B., J.L.C. and
G.C. performed the experiments. N.K., H.M.S., B.N.,
G.H.L., P.B., M.M.C. and J.B. analyzed and interpreted
data. N.K. and H.M.S. drafted the manuscript. All authors
revised manuscript for critically important intellectual con-
tent and approved the final version to be published (Kan-
war et al., 2014).
Explanation
A declaration of transparency should contain two parts: the
authors’ roles in the study and a declaration of complete
reporting. Declarations of transparency do not address any
potential bias within the study. They are primarily designed
to ensure that all authors meet the criteria for authorship.3
Those persons not meeting the authorship criteria can be
referenced in the acknowledgements section, but it is
unethical to include them as authors. The declaration of
complete reporting was proposed by Altman (Altman and
Moher, 2013) and is a statement acknowledging that the
data have been reported in their entirety and none of the
study has been omitted, thus reducing the potential for
selective reporting.
22 (d). Ethical approval – include information on ethical
approval for use of animal and human subjects
Example
The study was performed in adherence to the University of
Liverpool Animal Ethics Guidelines (Trehy et al., 2014).
Explanation
When studies involve animal use, authors must obtain ethi-
cal approval. It is consistent with best practices and trans-
parency to report the agency in charge of approval and a
verification number to identify the approval. In some stud-
ies, particularly those using questionnaires, authors must
document that they received approval for recruiting human
participants in research.
22 (e). Quality standards – describe any quality standards
used in the conduct of the research
Example
. . .reported according to the guidelines of the Strengthen-
ing the Reporting of Observational Studies in Epidemiology
(STROBE) statement, see additional information (STROBE
Checklist) for further details (Forand, 2004).
Explanation
When standards, such as STROBE, are available and have
been used, authors should explicitly state their use, so end-
users are aware of their implementation and can validate
that they were followed. Further, some standards are
lengthy, and it might be impractical to include a full
description of the methods employed in the paper. For
example, laboratory or animal welfare accreditations indi-
cate that certain practices and quality control approaches
were followed, and this information can help end-users
assess bias.
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